Search through our archive of speeches and presentations from conferences and events.
\nVisit our corporate reporting archive for our Annual Reports.
\nFor quarterly results materials visit quarterly results.
","categories":{},"enabledFilters":["year"],"searchYears":{"":"Year","2026":"2026","2025":"2025","2024":"2024","2023":"2023","2022":"2022","2021":"2021","2020":"2020","2019":"2019"},"captions":{"showMore":"Show more","mostRecent":"Most recent","mostRelevant":"Most relevant","search":"Search","download":"Download","resetSearch":"Reset search","clear":"Clear all","noResults":"We’re sorry, we can’t seem to find any search results matching your criteria.","resultsAvailable":"Results available","cancel":"Cancel","apply":"Apply","nowPlaying":"Now playing","paginationAriaLabel":"Pagination","previous":"previous","previousAriaLabel":"Go to previous page","next":"next","nextAriaLabel":"Go to next page","goToPageAriaLabel":"Go to page ##PAGE##","currentPageAriaLabel":"Page","numberOfResultsPerPage":"Number of results per page","playVideo":"Play video {title}","filterBy":"Filter By:","sortBy":"Sort By:","select":"Select","filterByYear":"Filter by year"},"counts":{"totalFound":118,"totalPages":2,"currentPage":1,"pageSize":100},"endpoint":"/api/search/blocklisting?parentId=6298&culture=en-GB","minimumSearchDate":null,"results":[{"itemId":10068,"headline":"Citi European Healthcare CEO Conference","introText":"Luke Miels, Chief Executive Officer, will attend the Citi European Healthcare CEO Conference in London on Wednesday, 10 June 2026.
","image":{"src":"/media/xqdbtzpm/luke-miels.jpg?rxy=0.5199311150900057,0.23700479694549298&width=900&height=600&format=webp&quality=100&v=1dc7bc7b9999230","alt":"Luke Miels","darkModeSrc":"/media/xqdbtzpm/luke-miels.jpg?rxy=0.5199311150900057,0.23700479694549298&width=900&height=600&format=webp&quality=50&v=1dc7bc7b9999230"},"imageOverlayText":"","imageCaption":"","date":"10 June 2026","links":[],"downloadAllLink":null},{"itemId":10067,"headline":"BNP Paribas Exane CEO Conference","introText":"Julie Brown, Chief Financial Officer, will attend the BNP Paribas Exane CEO Conference in Paris on Wednesday, 3 June 2026.
","image":{"src":"/media/fj4mgijo/glt-imagery-julie-brown-chief-financial-officer11.jpg?width=900&height=600&format=webp&quality=100&v=1dc00897a6919a0","alt":"Julie Brown","darkModeSrc":"/media/fj4mgijo/glt-imagery-julie-brown-chief-financial-officer11.jpg?width=900&height=600&format=webp&quality=50&v=1dc00897a6919a0"},"imageOverlayText":"","imageCaption":"","date":"03 June 2026","links":[],"downloadAllLink":null},{"itemId":10066,"headline":"Jefferies Global Healthcare Conference","introText":"Hesham Abdullah, SVP, Global Oncology R&D, will participate at the Jefferies Global Healthcare Conference in New York on Wednesday, 3 June 2026.
","image":{"src":"/media/fjffwi2b/ci8a9976.jpg?rxy=0.49,0.1675&width=900&height=600&format=webp&quality=100&v=1dba2ebb6049710","alt":"Hesham Abdullah portrait","darkModeSrc":"/media/fjffwi2b/ci8a9976.jpg?rxy=0.49,0.1675&width=900&height=600&format=webp&quality=50&v=1dba2ebb6049710"},"imageOverlayText":"","imageCaption":"","date":"03 June 2026","links":[],"downloadAllLink":null},{"itemId":10065,"headline":"Barclays European Leadership Conference","introText":"David Redfern, President Corporate Development, will attend the Barclays European Leadership Conference, taking place in London on Thursday, 21 May 2026.
","image":{"src":"/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebeffb4e00","alt":"David Redfern","darkModeSrc":"/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebeffb4e00"},"imageOverlayText":"","imageCaption":"","date":"21 May 2026","links":[],"downloadAllLink":null},{"itemId":10064,"headline":"Rothschild & Co Global Equities Conference","introText":"David Redfern, President Corporate Development, will attend the Rothschild & Co's upcoming Global Equities Conference in Toronto on Tuesday, 12 May 2026.
","image":{"src":"/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebeffb4e00","alt":"David Redfern","darkModeSrc":"/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebeffb4e00"},"imageOverlayText":"","imageCaption":"","date":"12 May 2026","links":[],"downloadAllLink":null},{"itemId":9993,"headline":"Goldman Sachs 9th Annual Biopharma Innovation Summit","introText":"Kaivan Khavandi, SVP, R&D Head, Respiratory, Immunology & Inflammation, participated in a fireside chat at the Goldman Sachs 9th Annual Biopharma Innovation Summit in London on Thursday, 26 March 2026 at 09:00 am GMT.
\nNo replay is available.
","image":{"src":"/media/fukp3c1q/kaivan-profile-image.jpg?rxy=0.5079921783122134,0.35586567815089404&width=900&height=600&format=webp&quality=100&v=1dcbba084fd5a70","alt":"Kaivan Khavandi","darkModeSrc":"/media/fukp3c1q/kaivan-profile-image.jpg?rxy=0.5079921783122134,0.35586567815089404&width=900&height=600&format=webp&quality=50&v=1dcbba084fd5a70"},"imageOverlayText":"","imageCaption":"","date":"26 March 2026","links":[],"downloadAllLink":null},{"itemId":9991,"headline":"BNP Paribas Healthcare Conference","introText":"Julie Brown, Chief Financial Officer, attended the BNP Paribas Healthcare Conference in London on Tuesday, 24 March 2026.
","image":{"src":"/media/foedxdzw/julie-b.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebae4c1e80","alt":"Julie Brown","darkModeSrc":"/media/foedxdzw/julie-b.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebae4c1e80"},"imageOverlayText":"","imageCaption":"","date":"24 March 2026","links":[],"downloadAllLink":null},{"itemId":9990,"headline":"Barclays 28th Annual Global Healthcare Conference","introText":"David Redfern, President Corporate Development, participated in a fireside chat at the Barclays 28th Annual Global Healthcare Conference in Miami, FL on Wednesday, 11 March 2026 at 11:30 am EST/4:30 pm GMT.
","image":{"src":"/media/vk5kqg4c/gskh_04_2022_port_david_02_hess.jpg?rxy=0.50886075949367093,0.35858585858585856&width=900&height=600&format=webp&quality=100&v=1dba2ebb05709b0","alt":"David Redfern","darkModeSrc":"/media/vk5kqg4c/gskh_04_2022_port_david_02_hess.jpg?rxy=0.50886075949367093,0.35858585858585856&width=900&height=600&format=webp&quality=50&v=1dba2ebb05709b0"},"imageOverlayText":"","imageCaption":"","date":"11 March 2026","links":[{"text":"Listen to the webcast","href":"https://event.webcasts.com/starthere.jsp?ei=1755067&tp_key=42d2e7c975&tp_special=8","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":9989,"headline":"Leerink Partners Global Healthcare Conference","introText":"David Redfern, President Corporate Development, attended the Leerink Partners Global Healthcare Conference in Miami, FL on Tuesday, 10 March 2026.
","image":{"src":"/media/vk5kqg4c/gskh_04_2022_port_david_02_hess.jpg?rxy=0.50886075949367093,0.35858585858585856&width=900&height=600&format=webp&quality=100&v=1dba2ebb05709b0","alt":"David Redfern","darkModeSrc":"/media/vk5kqg4c/gskh_04_2022_port_david_02_hess.jpg?rxy=0.50886075949367093,0.35858585858585856&width=900&height=600&format=webp&quality=50&v=1dba2ebb05709b0"},"imageOverlayText":"","imageCaption":"","date":"10 March 2026","links":[],"downloadAllLink":null},{"itemId":9988,"headline":"UBS European Healthcare Conference","introText":"David Redfern, President Corporate Development, attended the UBS European Healthcare Conference in London on Wednesday, 4 March 2026.
","image":{"src":"/media/vk5kqg4c/gskh_04_2022_port_david_02_hess.jpg?rxy=0.50886075949367093,0.35858585858585856&width=900&height=600&format=webp&quality=100&v=1dba2ebb05709b0","alt":"David Redfern","darkModeSrc":"/media/vk5kqg4c/gskh_04_2022_port_david_02_hess.jpg?rxy=0.50886075949367093,0.35858585858585856&width=900&height=600&format=webp&quality=50&v=1dba2ebb05709b0"},"imageOverlayText":"","imageCaption":"","date":"04 March 2026","links":[],"downloadAllLink":null},{"itemId":9924,"headline":"GSK enters agreement to acquire 35Pharma Inc.","introText":"Sell-side analysts calls with Nina Mojas, President, Global Product Strategy and Kaivan Khavandi, SVP, R&D Head, Respiratory, Immunology & Inflammation.
","image":{"src":"/media/vrbdwajb/gsk-and-35pharma-logo.jpg?width=900&height=600&format=webp&quality=100&v=1dca63acf89c9a0","alt":"GSK and 35Pharma","darkModeSrc":"/media/vrbdwajb/gsk-and-35pharma-logo.jpg?width=900&height=600&format=webp&quality=50&v=1dca63acf89c9a0"},"imageOverlayText":"","imageCaption":"","date":"25 February 2026","links":[{"name":"Download the presentation","url":"/media/mrwpanl2/agreement-to-acquire-35pharma-inc.pdf","fileExtension":"PDF","fileSize":"728.8KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":null},{"itemId":9823,"headline":"GSK enters agreement to acquire RAPT Therapeutics","introText":"Sell-side analysts calls with Luke Miels, Chief Executive Officer, Tony Wood, Chief Scientific Officer and Nina Mojas, President, Global Product Strategy.
","image":{"src":"/media/jzvdn1cl/gsk-and-rapt-logo.jpg?width=900&height=600&format=webp&quality=100&v=1dc8a1f5d946da0","alt":"GSK and RAPT logo","darkModeSrc":"/media/jzvdn1cl/gsk-and-rapt-logo.jpg?width=900&height=600&format=webp&quality=50&v=1dc8a1f5d946da0"},"imageOverlayText":"","imageCaption":"","date":"20 January 2026","links":[{"name":"Download the presentation","url":"/media/paddln2v/agreement-to-acquire-rapt-therapeutics-slides.pdf","fileExtension":"PDF","fileSize":"1.1MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":null},{"itemId":9664,"headline":"J.P. Morgan 2026 Healthcare Conference, San Francisco","introText":"Tony Wood, Chief Scientific Officer, participated in a fireside chat during the J.P. Morgan 2026 Healthcare Conference in San Francisco on Tuesday, 13 January 2026.
","image":{"src":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=900&height=600&format=webp&quality=100&v=1dc651e856734f0","alt":"Tony Wood","darkModeSrc":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=900&height=600&format=webp&quality=50&v=1dc651e856734f0"},"imageOverlayText":"","imageCaption":"","date":"13 January 2026","links":[{"name":"See recent quarterly results slides Q3 2025","url":"/media/0qfjbtd3/q3-2025-results-slides.pdf","fileExtension":"PDF","fileSize":"667.1KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"See recent quarterly results slides Q2 2025","url":"/media/fonb14xu/q2-2025-results-slides.pdf","fileExtension":"PDF","fileSize":"1.3MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=9627,9491&name=J.P. Morgan 2026 Healthcare Conference, San Francisco","openInNewWindowText":null}},{"itemId":9662,"headline":"Citi 2025 Global Healthcare Conference, Miami","introText":"Deborah Waterhouse, Chief Executive Officer of ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D at ViiV Healthcare, participated at the Citi 2025 Global Healthcare Conference in Miami on Thursday, 4 December 2025.
","image":{"src":"/media/t00bmup1/kim-and-deborah.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebd1d76490","alt":"Deborah and Kimberly","darkModeSrc":"/media/t00bmup1/kim-and-deborah.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebd1d76490"},"imageOverlayText":"","imageCaption":"","date":"04 December 2025","links":[{"text":"Listen to the webcast","href":"https://kvgo.com/global-healthcare-conference-2025/gsk-plc-december-2025","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":9663,"headline":"Evercore 8th Annual Evercore Healthcare Conference, Miami","introText":"Deborah Waterhouse, Chief Executive Officer of ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D at ViiV Healthcare, participated at the Evercore 8th Annual Evercore Healthcare Conference in Miami on Wednesday, 3 December 2025.
","image":{"src":"/media/sedfczop/deborah-and-kim.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebce79e1b0","alt":"Deborah and Kim headshots","darkModeSrc":"/media/sedfczop/deborah-and-kim.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebce79e1b0"},"imageOverlayText":"","imageCaption":"","date":"03 December 2025","links":[],"downloadAllLink":null},{"itemId":9603,"headline":"Jefferies London Healthcare Conference, London","introText":"Tony Wood, Chief Scientific Officer, attended the Jefferies Healthcare Conference in London on Tuesday, 18 and Wednesday, 19 November 2025.
","image":{"src":"/media/ztmb1w5s/stvg_04_2022_port_tony_05_hess_27200.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebb2fc8730","alt":"Tony Wood","darkModeSrc":"/media/ztmb1w5s/stvg_04_2022_port_tony_05_hess_27200.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebb2fc8730"},"imageOverlayText":"","imageCaption":"","date":"18 November 2025","links":[],"downloadAllLink":null},{"itemId":9602,"headline":"J.P. Morgan UK Leaders Conference, London","introText":"Julie Brown, Chief Financial Officer, attended the J.P. Morgan UK Leaders Conference in London on Tuesday, 18 November 2025.
","image":{"src":"/media/fj4mgijo/glt-imagery-julie-brown-chief-financial-officer11.jpg?width=900&height=600&format=webp&quality=100&v=1dc00897a6919a0","alt":"Julie Brown","darkModeSrc":"/media/fj4mgijo/glt-imagery-julie-brown-chief-financial-officer11.jpg?width=900&height=600&format=webp&quality=50&v=1dc00897a6919a0"},"imageOverlayText":"","imageCaption":"","date":"18 November 2025","links":[],"downloadAllLink":null},{"itemId":9601,"headline":"UBS European Conference, London","introText":"David Redfern, President Corporate Development, attended the UBS European Conference in London on Wednesday, 12 November 2025.
","image":{"src":"/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebeffb4e00","alt":"David Redfern","darkModeSrc":"/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebeffb4e00"},"imageOverlayText":"","imageCaption":"","date":"12 November 2025","links":[],"downloadAllLink":null},{"itemId":9408,"headline":"BofA 2025 Global Healthcare Conference, London","introText":"Julie Brown, Chief Financial Officer and Tony Wood, Chief Scientific Officer, participated in a fireside chat at the BofA Global Healthcare Conference in London on Wednesday, 24 September 2025.
","image":{"src":"/media/pvibrwwc/julie-brown-tony-wood-16x9.jpg?width=900&height=600&format=webp&quality=100&v=1dbef2fba9bb6b0","alt":"Julie Brown Tony Wood 16X9","darkModeSrc":"/media/pvibrwwc/julie-brown-tony-wood-16x9.jpg?width=900&height=600&format=webp&quality=50&v=1dbef2fba9bb6b0"},"imageOverlayText":"","imageCaption":"","date":"24 September 2025","links":[{"text":"Listen to the webcast","href":"https://bofa.veracast.com/webcasts/bofa/globalhealthcareuk2025/Y4G9dM.cfm","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":9406,"headline":"Morgan Stanley 23rd Annual Global Healthcare Conference, New York","introText":"Hesham Abdullah, SVP, Global Oncology R&D, participated at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York on Tuesday, 9 September 2025.
","image":{"src":"/media/uiwnz3xl/hesham-photo-navy-blue-10may23-teams-outlook-workday-683x1024.jpg?rxy=0.43166666666666664,0.39222222222222225&width=900&height=600&format=webp&quality=100&v=1dba2ebb612eef0","alt":"Hesham Abdullah standing in front of the office","darkModeSrc":"/media/uiwnz3xl/hesham-photo-navy-blue-10may23-teams-outlook-workday-683x1024.jpg?rxy=0.43166666666666664,0.39222222222222225&width=900&height=600&format=webp&quality=50&v=1dba2ebb612eef0"},"imageOverlayText":"","imageCaption":"","date":"09 September 2025","links":[],"downloadAllLink":null},{"itemId":9243,"headline":"Citi European Healthcare Conference, London","introText":"Tony Wood, Chief Scientific Officer, attended the Citi European Healthcare Conference in London on Tuesday, 17 June 2025.
","image":{"src":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=900&height=600&format=webp&quality=100&v=1dc651e856734f0","alt":"Tony Wood","darkModeSrc":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=900&height=600&format=webp&quality=50&v=1dc651e856734f0"},"imageOverlayText":"","imageCaption":"","date":"17 June 2025","links":[],"downloadAllLink":null},{"itemId":9241,"headline":"Goldman Sachs Global Healthcare Conference, Miami","introText":"Kimberly Smith, Head of R&D at ViiV Healthcare, attended the Goldman Sachs Global Healthcare Conference in Miami on Monday, 9 June 2025.
","image":{"src":"/media/nnwpsa0f/dr-kimberly_smith092.jpg?width=900&height=600&format=webp&quality=100&v=1dbc666f3953f50","alt":"Dr Kimberly Smith","darkModeSrc":"/media/nnwpsa0f/dr-kimberly_smith092.jpg?width=900&height=600&format=webp&quality=50&v=1dbc666f3953f50"},"imageOverlayText":"","imageCaption":"","date":"09 June 2025","links":[],"downloadAllLink":null},{"itemId":9242,"headline":"NYSE Health Care Virtual Investor Access Day","introText":"David Redfern, President Corporate Development, attended the NYSE Health Care Virtual Investor Access Day on Thursday, 5 June 2025.
","image":{"src":"/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebeffb4e00","alt":"David Redfern","darkModeSrc":"/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebeffb4e00"},"imageOverlayText":"","imageCaption":"","date":"05 June 2025","links":[],"downloadAllLink":null},{"itemId":9240,"headline":"BNP Paribas Exane CEO Conference, Paris","introText":"Julie Brown, Chief Financial Officer, attended the BNP Paribas Exane CEO Conference in Paris on Thursday, 5 June 2025.
","image":{"src":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=100&v=1dba2ebb0051920","alt":"Julie Brown sat on a grey sofa smiling","darkModeSrc":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=50&v=1dba2ebb0051920"},"imageOverlayText":"","imageCaption":"","date":"05 June 2025","links":[],"downloadAllLink":null},{"itemId":8152,"headline":"Goldman Sachs Biopharma Innovation Summit","introText":"David Redfern, President, Corporate Development, attended the Goldman Sachs Biopharma Innovation Summit in London on Thursday, 27 March 2025.
","image":{"src":"/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebeffb4e00","alt":"David Redfern","darkModeSrc":"/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebeffb4e00"},"imageOverlayText":"","imageCaption":"","date":"27 March 2025","links":[],"downloadAllLink":null},{"itemId":8153,"headline":"BNP Paribas Exane Healthcare Conference","introText":"Julie Brown, Chief Financial Officer, participated in a virtual fireside chat at the BNP Paribas Exane Healthcare Conference on Tuesday, 25 March 2025.
","image":{"src":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=100&v=1dba2ebb0051920","alt":"Julie Brown sat on a grey sofa smiling","darkModeSrc":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=50&v=1dba2ebb0051920"},"imageOverlayText":"","imageCaption":"","date":"25 March 2025","links":[],"downloadAllLink":null},{"itemId":8154,"headline":"TD Cowen 45th Annual Health Care Conference","introText":"Luke Miels, Chief Commercial Officer, participated in a fireside chat at the TD Cowen 45th Annual Health Care Conference in Boston on Monday, 3 March 2025.
","image":{"src":"/media/dsghk01j/gskh_05_2022_port_luke_03_sinden_thumb.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebef88dd20","alt":"Luke Miels","darkModeSrc":"/media/dsghk01j/gskh_05_2022_port_luke_03_sinden_thumb.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebef88dd20"},"imageOverlayText":"","imageCaption":"","date":"03 March 2025","links":[],"downloadAllLink":null},{"itemId":8155,"headline":"43rd Annual J.P. Morgan Healthcare Conference","introText":"Emma Walmsley, Chief Executive Officer, presented at the 43rd annual JP Morgan Healthcare Conference on Tuesday 14 January. The 40 minute session included a presentation and a moderated Q&A discussion.
","image":{"src":"/media/bl0nwhzx/gskh_05_2022_port_emma_03_hess.jpg?rxy=0.58227848101265822,0.32323232323232326&width=900&height=600&format=webp&quality=100&v=1dba2ebb14a9170","alt":"Emma Walmsley","darkModeSrc":"/media/bl0nwhzx/gskh_05_2022_port_emma_03_hess.jpg?rxy=0.58227848101265822,0.32323232323232326&width=900&height=600&format=webp&quality=50&v=1dba2ebb14a9170"},"imageOverlayText":"","imageCaption":"","date":"14 January 2025","links":[{"name":"JP Morgan Healthcare Conference presentation","url":"/media/oxpbkchk/gsk-2025-jpm-conf-presentation-14-january-2025.pdf","fileExtension":"PDF","fileSize":"925.5KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":null},{"itemId":8157,"headline":"Meet the management: Early pipeline","introText":"On 17 December, GSK management held a virtual event, \"Early pipeline\", featuring a presentation and an interactive Q&A session.
","image":{"src":"/media/nfnb0ocv/dna-and-tech-image.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebd1691260","alt":"GSK Dna And Tech Image","darkModeSrc":"/media/nfnb0ocv/dna-and-tech-image.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebd1691260"},"imageOverlayText":"","imageCaption":"","date":"17 December 2024","links":[{"text":"Watch the recording","href":"https://www.youtube.com/watch?v=_SQKS9TgcxU","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"},{"name":"Meet the management: Early pipeline presentation","url":"/media/msnj0zn0/meet-the-management-early-pipeline-presentation.pdf","fileExtension":"PDF","fileSize":"2.7MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Meet the management: Early pipeline transcript","url":"/media/snpft0zy/meet-the-management-early-pipeline-transcript.pdf","fileExtension":"PDF","fileSize":"295.5KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4981,4980&name=Meet the management: Early pipeline","openInNewWindowText":null}},{"itemId":8156,"headline":"Getting Ahead of Multiple Myeloma: Update from ASH","introText":"GSK held a virtual event \"Getting Ahead of Multiple Myeloma: Update from ASH\" on 10 December, providing a recap on data presented at the 66th ASH (American Society of Hematology) Annual Meeting.
","image":{"src":"/media/dpwhy5qp/multiple-myeloma-science-image.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebb728a4b0","alt":"Multiple Myeloma Science Image","darkModeSrc":"/media/dpwhy5qp/multiple-myeloma-science-image.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebb728a4b0"},"imageOverlayText":"","imageCaption":"","date":"10 December 2024","links":[{"text":"Watch the recording","href":"https://gsk.zoom.us/webinar/register/WN_E2SWPJKpS5K0d9qM0W455Q","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"},{"name":"Getting Ahead of Multiple Myeloma presentation","url":"/media/gfjivioc/gsk-ash-analyst-call-presentation_final.pdf","fileExtension":"PDF","fileSize":"1.1MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Getting Ahead of Multiple Myeloma transcript","url":"/media/ifolzuz1/gsk-ash_analyst-call-transcript_final.pdf","fileExtension":"PDF","fileSize":"236.8KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4982,4977&name=Getting Ahead of Multiple Myeloma: Update from ASH","openInNewWindowText":null}},{"itemId":8158,"headline":"Citi's 2024 Global Healthcare Conference","introText":"Hesham Abdullah, SVP Global Head Oncology, attended Citi's 2024 Global Healthcare Conference in Miami on Thursday, 5 December 2024.
","image":{"src":"/media/uiwnz3xl/hesham-photo-navy-blue-10may23-teams-outlook-workday-683x1024.jpg?rxy=0.43166666666666664,0.39222222222222225&width=900&height=600&format=webp&quality=100&v=1dba2ebb612eef0","alt":"Hesham Abdullah standing in front of the office","darkModeSrc":"/media/uiwnz3xl/hesham-photo-navy-blue-10may23-teams-outlook-workday-683x1024.jpg?rxy=0.43166666666666664,0.39222222222222225&width=900&height=600&format=webp&quality=50&v=1dba2ebb612eef0"},"imageOverlayText":"","imageCaption":"","date":"05 December 2024","links":[],"downloadAllLink":null},{"itemId":8159,"headline":"The 2024 Redburn Atlantic CEO Conference","introText":"Emma Walmsley, Chief Executive Officer, participated in a virtual fireside chat at the 2024 Redburn Atlantic CEO Conference on Wednesday, 4 December 2024.
","image":{"src":"/media/srkhy1nz/gskh_05_2022_port_emma_03_hess_thumb.jpg?rxy=0.56833333333333336,0.48666666666666669&width=900&height=600&format=webp&quality=100&v=1dba2ebef61a610","alt":"Dame Emma Walmsley","darkModeSrc":"/media/srkhy1nz/gskh_05_2022_port_emma_03_hess_thumb.jpg?rxy=0.56833333333333336,0.48666666666666669&width=900&height=600&format=webp&quality=50&v=1dba2ebef61a610"},"imageOverlayText":"","imageCaption":"","date":"04 December 2024","links":[],"downloadAllLink":null},{"itemId":8160,"headline":"7th Annual Evercore ISI HealthCONx Conference","introText":"Phil Dormitzer, SVP, Head of Vaccines R&D, attended the 7th Annual Evercore ISI HealthCONx Conference in Miami on Wednesday, 4 December 2024.
","image":{"src":"/media/bu0bd4we/phil-dormitzer.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebce54a670","alt":"Phil Dormitzer headshot","darkModeSrc":"/media/bu0bd4we/phil-dormitzer.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebce54a670"},"imageOverlayText":"","imageCaption":"","date":"04 December 2024","links":[],"downloadAllLink":null},{"itemId":8161,"headline":"Bernstein Premium Review Conference","introText":"David Redfern, President Corporate Development, attended the Bernstein Premium Review Conference in Paris on Wednesday, 27 November 2024.
","image":{"src":"/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebeeeec000","alt":"David Redfern","darkModeSrc":"/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebeeeec000"},"imageOverlayText":"","imageCaption":"","date":"27 November 2024","links":[],"downloadAllLink":null},{"itemId":8162,"headline":"Jefferies London Healthcare Conference ","introText":"Tony Wood, Chief Scientific Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, 19 November 2024 in London.
","image":{"src":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=900&height=600&format=webp&quality=100&v=1dc651e856734f0","alt":"Tony Wood","darkModeSrc":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=900&height=600&format=webp&quality=50&v=1dc651e856734f0"},"imageOverlayText":"","imageCaption":"","date":"19 November 2024","links":[],"downloadAllLink":null},{"itemId":8163,"headline":"JP Morgan UK Leaders Conference","introText":"Julie Brown, Chief Financial Officer, participated in a fireside chat at the JP Morgan UK Leaders Conference on Tuesday, 19 November 2024 in London.
","image":{"src":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=100&v=1dba2ebb0051920","alt":"Julie Brown sat on a grey sofa smiling","darkModeSrc":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=50&v=1dba2ebb0051920"},"imageOverlayText":"","imageCaption":"","date":"19 November 2024","links":[],"downloadAllLink":null},{"itemId":8164,"headline":"Guggenheim's Inaugural Healthcare Innovation Conference","introText":"Emma Walmsley, Chief Executive Officer, participated in a fireside chat at Guggenheim's Inaugural Healthcare Innovation Conference on Tuesday, 12 November 2024 in Boston.
","image":{"src":"/media/bl0nwhzx/gskh_05_2022_port_emma_03_hess.jpg?rxy=0.58227848101265822,0.32323232323232326&width=900&height=600&format=webp&quality=100&v=1dba2ebb14a9170","alt":"Emma Walmsley","darkModeSrc":"/media/bl0nwhzx/gskh_05_2022_port_emma_03_hess.jpg?rxy=0.58227848101265822,0.32323232323232326&width=900&height=600&format=webp&quality=50&v=1dba2ebb14a9170"},"imageOverlayText":"","imageCaption":"","date":"12 November 2024","links":[],"downloadAllLink":null},{"itemId":8165,"headline":"Bernstein 21st Pan European Annual Strategic Decisions Conference","introText":"David Redfern, President, Corporate Development, attended the Bernstein 21st Pan European Annual Strategic Decisions Conference in London on Wednesday, 25 September 2024.
","image":{"src":"/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebeeeec000","alt":"David Redfern","darkModeSrc":"/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebeeeec000"},"imageOverlayText":"","imageCaption":"","date":"25 September 2024","links":[],"downloadAllLink":null},{"itemId":8166,"headline":"BofA 2024 Global Healthcare Conference, London","introText":"Julie Brown, Chief Financial Officer, participated in a fireside chat at the BofA Global Healthcare Conference on Thursday, 19 September 2024 in London at 09:05 BST.
","image":{"src":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=100&v=1dba2ebb0051920","alt":"Julie Brown sat on a grey sofa smiling","darkModeSrc":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=50&v=1dba2ebb0051920"},"imageOverlayText":"","imageCaption":"","date":"19 September 2024","links":[],"downloadAllLink":null},{"itemId":8167,"headline":"Morgan Stanley 22nd Annual Global Healthcare Conference, NYC","introText":"David Redfern, President, Corporate Development, participated in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference taking place in New York on Thursday, 5 September 2024 at 4:05am EST.
","image":{"src":"/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebeeeec000","alt":"David Redfern","darkModeSrc":"/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebeeeec000"},"imageOverlayText":"","imageCaption":"","date":"05 September 2024","links":[],"downloadAllLink":null},{"itemId":8168,"headline":"Getting ahead of Oncology with GSK management","introText":"GSK management held a virtual event on 17 June at 8:00 AM EDT / 1:00 PM BST. The event, \"Getting Ahead of Oncology,\" featured a presentation and an interactive Q&A session. A replay is available on demand.
","image":{"src":"/media/hmljdzsk/endometrial-cancer-science-image-rgb.jpg?rxy=0.34333333333333332,0.57100591715976334&width=900&height=600&format=webp&quality=100&v=1dba2ec0d37bda0","alt":"Endometrial Cancer Science Image","darkModeSrc":"/media/hmljdzsk/endometrial-cancer-science-image-rgb.jpg?rxy=0.34333333333333332,0.57100591715976334&width=900&height=600&format=webp&quality=50&v=1dba2ec0d37bda0"},"imageOverlayText":"","imageCaption":"","date":"17 June 2024","links":[{"text":"Watch the recording","href":"https://youtu.be/rIBaUlr4XqA","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"},{"name":"Getting ahead of Oncology presentation","url":"/media/jhgjf5m3/getting-ahead-of-oncology-presentation.pdf","fileExtension":"PDF","fileSize":"3.0MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Getting ahead of Oncology transcript","url":"/media/fbhni5vm/getting-ahead-of-oncology-transcript.pdf","fileExtension":"PDF","fileSize":"265.6KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4974,4973&name=Getting ahead of Oncology with GSK management","openInNewWindowText":null}},{"itemId":8169,"headline":"BNP Paribas Exane CEO Conference","introText":"Julie Brown, Chief Financial Officer, participated in a fireside chat at the BNP Paribas Exane CEO Conference in Paris on Thursday, 6 June 2024.
","image":{"src":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=100&v=1dba2ebb0051920","alt":"Julie Brown sat on a grey sofa smiling","darkModeSrc":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=50&v=1dba2ebb0051920"},"imageOverlayText":"","imageCaption":"","date":"06 June 2024","links":[],"downloadAllLink":null},{"itemId":8170,"headline":"J.P. Morgan EMEA All Stars Forum","introText":"David Redfern, President, Corporate Development, attended the J.P. Morgan EMEA All Stars Forum in Boston on Wednesday, 22 May 2024.
","image":{"src":"/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebeeeec000","alt":"David Redfern","darkModeSrc":"/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebeeeec000"},"imageOverlayText":"","imageCaption":"","date":"22 May 2024","links":[],"downloadAllLink":null},{"itemId":8171,"headline":"Berenberg European Conference","introText":"David Redfern, President, Corporate Development, attended the Berenberg European Conference in New York on Tuesday, 21 May 2024.
","image":{"src":"/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebeeeec000","alt":"David Redfern","darkModeSrc":"/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebeeeec000"},"imageOverlayText":"","imageCaption":"","date":"21 May 2024","links":[],"downloadAllLink":null},{"itemId":8172,"headline":"Barclays European Select Conference","introText":"David Redfern, President, Corporate Development, attended the Barclays European Select Conference in New York on Monday, 20 May 2024.
","image":{"src":"/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebeeeec000","alt":"David Redfern","darkModeSrc":"/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebeeeec000"},"imageOverlayText":"","imageCaption":"","date":"20 May 2024","links":[],"downloadAllLink":null},{"itemId":8174,"headline":"BNP Paribas Exane Healthcare Conference, Virtual","introText":"Julie Brown, Chief Financial Officer, participated in a fireside chat at the BNP Paribas Exane Healthcare Conference which took place on Tuesday, 26 March 2024.
","image":{"src":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=100&v=1dba2ebb0051920","alt":"Julie Brown sat on a grey sofa smiling","darkModeSrc":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=50&v=1dba2ebb0051920"},"imageOverlayText":"","imageCaption":"","date":"26 March 2024","links":[],"downloadAllLink":null},{"itemId":8176,"headline":"ESG Investor Education Event (ESG Performance Report)","introText":"GSK’s VP of Reputation and Responsible Business, Clare Griffin, and VP of Sustainability, Claire Lund, presented a 45 minute virtual event focused on the newest set of ESG data for the company – the 2023 ESG Performance Report.
","image":{"src":"/media/30qjl55f/esg-report-2023-conference.jpg?rxy=0.28666666666666668,0.51183431952662717&width=900&height=600&format=webp&quality=100&v=1dba2ebce2f9240","alt":"GSK human tech image with ESG Performance Report 2023 copy","darkModeSrc":"/media/30qjl55f/esg-report-2023-conference.jpg?rxy=0.28666666666666668,0.51183431952662717&width=900&height=600&format=webp&quality=50&v=1dba2ebce2f9240"},"imageOverlayText":"","imageCaption":"","date":"19 March 2024","links":[{"text":"Watch the webcast","href":"https://youtu.be/em0EF-xaHOI","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"},{"name":"Presentation","url":"/media/fjbgkye0/esg-investor-education-event-esg-performance-report-presentation.pdf","fileExtension":"PDF","fileSize":"325.0KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Transcript","url":"/media/hbif2nbf/esg-investor-education-event-esg-performance-report-transcript.pdf","fileExtension":"PDF","fileSize":"90.8KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4971,4970&name=ESG Investor Education Event (ESG Performance Report)","openInNewWindowText":null}},{"itemId":8175,"headline":"Berenberg UK Corporate Conference, Watford","introText":"Julie Brown, Chief Financial Officer, attended the Berenberg UK Corporate Conference on Tuesday, 19 March 2024.
","image":{"src":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=100&v=1dba2ebb0051920","alt":"Julie Brown sat on a grey sofa smiling","darkModeSrc":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=50&v=1dba2ebb0051920"},"imageOverlayText":"","imageCaption":"","date":"19 March 2024","links":[],"downloadAllLink":null},{"itemId":8177,"headline":"TD Cowen Healthcare Conference","introText":"Luke Miels, Chief Commercial Officer, participated in a fireside chat at TD Cowen's Healthcare Conference taking place on Monday 4 March at 2:50pm ET / 7:50pm GMT.
","image":{"src":"/media/s2bfepc3/luke-miels-389-edit.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd14eac90","alt":"Luke Miels","darkModeSrc":"/media/s2bfepc3/luke-miels-389-edit.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd14eac90"},"imageOverlayText":"","imageCaption":"","date":"04 March 2024","links":[{"text":"Listen to the webcast","href":"https://wsw.com/webcast/cowen154/gsk/1852462","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8173,"headline":"UBS European Healthcare Conference, London","introText":"Julie Brown, Chief Financial Officer, attended the London UBS European Healthcare Conference on Tuesday, 28 February 2024.
","image":{"src":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=100&v=1dba2ebb0051920","alt":"Julie Brown sat on a grey sofa smiling","darkModeSrc":"/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg?rxy=0.33333333333333331,0.4775&width=900&height=600&format=webp&quality=50&v=1dba2ebb0051920"},"imageOverlayText":"","imageCaption":"","date":"28 February 2024","links":[],"downloadAllLink":null},{"itemId":8178,"headline":"42nd annual JP Morgan Healthcare Conference","introText":"Emma Walmsley, Chief Executive Officer, participated in the 42nd annual JP Morgan Healthcare Conference on Tuesday 9 January at 07:30-08:10am PST / 15:30-16:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion.
","image":{"src":"/media/octpfn4c/gskh_05_2022_port_emma_03_hess_thumb.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebd9d6aa20","alt":"Dame Emma Walmsley","darkModeSrc":"/media/octpfn4c/gskh_05_2022_port_emma_03_hess_thumb.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebd9d6aa20"},"imageOverlayText":"","imageCaption":"","date":"09 January 2024","links":[{"text":"Listen to the webcast","href":"https://jpmorgan.metameetings.net/events/healthcare24/sessions/49293-gsk/webcast?gpu_only=true&kiosk=true","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"},{"name":"JP Morgan Healthcare Conference presentation","url":"/media/rmllhk1d/2024-jp-morgan-healthcare-conference-presentation.pdf","fileExtension":"PDF","fileSize":"1.0MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"JP Morgan Healthcare Conference transcript","url":"/media/tsvlrat3/jp-morgan-healthcare-conference-transcript.pdf","fileExtension":"PDF","fileSize":"81.2KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4967,4968&name=42nd annual JP Morgan Healthcare Conference","openInNewWindowText":null}},{"itemId":8182,"headline":"Getting ahead of Respiratory Diseases with GSK management","introText":"GSK management held a virtual event on 30 November at 8:00 AM EST / 1:00 PM GMT. The event featured a presentation and an interactive Q&A session. A replay is available on demand.
","image":{"src":"/media/a1papyuy/lungs-science-image.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebce436860","alt":"Lungs science image","darkModeSrc":"/media/a1papyuy/lungs-science-image.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebce436860"},"imageOverlayText":"","imageCaption":"","date":"30 November 2023","links":[{"text":"Watch the recording","href":"https://youtu.be/DCFrv0h2yhc","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"},{"name":"Getting ahead of respiratory diseases presentation","url":"/media/5aepp4r0/gsk_respi-mtm_getting-ahead-of-respiratory-diseases.pdf","fileExtension":"PDF","fileSize":"4.6MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Getting ahead of respiratory diseases transcript","url":"/media/sbspp0i2/getting-ahead-of-respiratory-diseases-with-gsk-management-transcript.pdf","fileExtension":"PDF","fileSize":"134.0KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4962,4963&name=Getting ahead of Respiratory Diseases with GSK management","openInNewWindowText":null}},{"itemId":8181,"headline":"Evercore ISI HealthCONx Conference","introText":"Phil Dormitzer, SVP and Global Head Vaccines R&D and Infectious Disease Research, discussed the progress being made in vaccine innovation during a fireside chat at the Evercore ISI HealthCONx Conference on Wednesday, 29 November 2023, 12:30pm UK / 7:30am ET.
","image":{"src":"/media/bu0bd4we/phil-dormitzer.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebce54a670","alt":"Phil Dormitzer headshot","darkModeSrc":"/media/bu0bd4we/phil-dormitzer.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebce54a670"},"imageOverlayText":"","imageCaption":"","date":"29 November 2023","links":[{"text":"Listen to the webcast","href":"https://wsw.com/webcast/evercore39/gsk/2177059","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8180,"headline":"Redburn Atlantic CEO Conference","introText":"Luke Miels, Chief Commercial Officer, discussed the progress being made at GSK during a fireside chat at the Redburn Atlantic CEO Conference on Wednesday, 29 November 2023 at 9:00am UK.
","image":{"src":"/media/s2bfepc3/luke-miels-389-edit.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd14eac90","alt":"Luke Miels","darkModeSrc":"/media/s2bfepc3/luke-miels-389-edit.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd14eac90"},"imageOverlayText":"","imageCaption":"","date":"29 November 2023","links":[{"text":"Watch the webcast","href":"https://wsw.com/webcast/redburn7/gsk/1989197","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8179,"headline":"Jefferies London Healthcare Conference","introText":"Tony Wood, Chief Scientific Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Thursday, 16 November at 9:00am GMT.
","image":{"src":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=900&height=600&format=webp&quality=100&v=1dc651e856734f0","alt":"Tony Wood","darkModeSrc":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=900&height=600&format=webp&quality=50&v=1dc651e856734f0"},"imageOverlayText":"","imageCaption":"","date":"16 November 2023","links":[{"text":"Watch the webcast","href":"https://wsw.com/webcast/jeff287/gsk/1707404","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8183,"headline":"Getting ahead of HIV with ViiV Healthcare management","introText":"ViiV Healthcare management held a virtual event on 28 September at 9:00 AM EDT / 2:00 PM BST. The event, \"Getting ahead of HIV,\" featured a presentation and an interactive Q&A. A recording of the session is available on YouTube.
","image":{"src":"/media/hkuiwef2/hiv_octane_ry_6k_still_1280x720px.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ec0a689810","alt":"HIV cell","darkModeSrc":"/media/hkuiwef2/hiv_octane_ry_6k_still_1280x720px.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ec0a689810"},"imageOverlayText":"","imageCaption":"","date":"28 September 2023","links":[{"text":"Watch the recording","href":"https://www.youtube.com/watch?v=vyKGSHZ_xSs","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"},{"name":"Getting ahead of HIV together presentation","url":"/media/bjxlq3hp/gsk_viiv-mtm_getting-ahead-of-hiv-together_20230928.pdf","fileExtension":"PDF","fileSize":"1.4MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Getting ahead of HIV together transcript","url":"/media/0qrlbtd4/getting-ahead-of-hiv-together-transcript.pdf","fileExtension":"PDF","fileSize":"231.8KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4959,4958&name=Getting ahead of HIV with ViiV Healthcare management","openInNewWindowText":null}},{"itemId":8184,"headline":"BofA 2023 Global Healthcare Conference","introText":"Emma Walmsley, Chief Executive Officer, participated in a fireside chat at the BofA Global Healthcare Conference on Thursday 14 September at 09:05 BST.
","image":{"src":"/media/octpfn4c/gskh_05_2022_port_emma_03_hess_thumb.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebd9d6aa20","alt":"Dame Emma Walmsley","darkModeSrc":"/media/octpfn4c/gskh_05_2022_port_emma_03_hess_thumb.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebd9d6aa20"},"imageOverlayText":"","imageCaption":"","date":"14 September 2023","links":[{"text":"Listen to the webcast","href":"https://bofa.veracast.com/webcasts/bofa/globalhealthcareuk2023/id59v9PR.cfm","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8185,"headline":"Citi’s 18th Annual BioPharma Conference","introText":"Phil Dormitzer, SVP, Head of Vaccines R&D joined Andrew Baum in a fireside chat at Citi’s 18th Annual BioPharma Conference which took place Thursday, September 7th at 8:50am ET/1:50pm UK.
","image":{"src":"/media/bu0bd4we/phil-dormitzer.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebce54a670","alt":"Phil Dormitzer headshot","darkModeSrc":"/media/bu0bd4we/phil-dormitzer.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebce54a670"},"imageOverlayText":"","imageCaption":"","date":"07 September 2023","links":[{"text":"Listen to the webcast","href":"https://kvgo.com/citi/gsk-plc-sept-2023","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8186,"headline":"Getting ahead of Infectious Disease with GSK management","introText":"The virtual event featured a presentation, four breakout sessions and an interactive Q&A. Recordings of all sessions are available on YouTube.
Tony Wood, Chief Scientific Officer, discussed progress made in R&D during a fireside chat on Tuesday, 13 June at 9:20am PT/12:20pm ET/5:20pm UK during Goldman Sachs’ 44th Annual Global Healthcare Conference, in Dana Point, California.
","image":{"src":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=900&height=600&format=webp&quality=100&v=1dc651e856734f0","alt":"Tony Wood","darkModeSrc":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=900&height=600&format=webp&quality=50&v=1dc651e856734f0"},"imageOverlayText":"","imageCaption":"","date":"13 June 2023","links":[{"name":"Download audio","url":"/media/cm1ma4ex/gsk-goldman-sachs-global-healthcare-conference-audio.mp3","fileExtension":"MP3","fileSize":"7.7MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":null},{"itemId":8188,"headline":"ESG Investor Education Event (Clinical Trial Diversity)","introText":"During the 45 minute session Alberto Fernandez, SVP of Global Clinical Operations at GSK and Dr. Kimberly Smith, SVP and Head of R&D at ViiV Healthcare, provided insights on the importance of clinical trial diversity including support from a 17-year retrospective study. During the session, the leaders also provided an overview of GSK’s work to ensure clinical trials reflect the populations most impacted by a disease and explored a HIV case study that demonstrated the power of clinical trial diversity in action. The presentation was followed by an opportunity for audience Q&A.
","image":{"src":"/media/foonktgv/esg-investor-education-event-clinical-trial-diversity.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebce6680c0","alt":"Clinical Trial Diversity","darkModeSrc":"/media/foonktgv/esg-investor-education-event-clinical-trial-diversity.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebce6680c0"},"imageOverlayText":"","imageCaption":"","date":"06 June 2023","links":[{"name":"Download audio","url":"/media/sh3pwtfi/399015083.mp3","fileExtension":"MP3","fileSize":"5.1MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Clinical Trial Diversity presentation","url":"/media/qvkhuc2o/clinical-trial-diversity-presentation.pdf","fileExtension":"PDF","fileSize":"1.8MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=5788,4942&name=ESG Investor Education Event (Clinical Trial Diversity)","openInNewWindowText":null}},{"itemId":8190,"headline":"41st annual JP Morgan Healthcare Conference ","introText":"Emma Walmsley, Chief Executive Officer, presented at the 41st annual JP Morgan Healthcare Conference on Tuesday 10 January at 07:30-08:10am PT / 15:30-16:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion.
","image":{"src":"/media/ixfplhy0/gskh_05_2022_port_emma_04_hess.jpg?rxy=0.39166666666666666,0.599406528189911&width=900&height=600&format=webp&quality=100&v=1dba2ebcba0f820","alt":"Emma Walmsley in a blue dress ","darkModeSrc":"/media/ixfplhy0/gskh_05_2022_port_emma_04_hess.jpg?rxy=0.39166666666666666,0.599406528189911&width=900&height=600&format=webp&quality=50&v=1dba2ebcba0f820"},"imageOverlayText":"","imageCaption":"","date":"10 January 2023","links":[{"name":"Download audio","url":"/media/10snqu1g/gsk-jpm-presentation-10-jan-2023.mp3","fileExtension":"MP3","fileSize":"17.6MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"JP Morgan Healthcare Conference Presentation","url":"/media/22dklggv/20230109-cnfr-jpmorgan-prsn-all-sent.pdf","fileExtension":"PDF","fileSize":"5.0MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"JP Morgan Healthcare Conference Transcript","url":"/media/3qtakwu1/gsk-jpm-transcript-10-jan-2023.pdf","fileExtension":"PDF","fileSize":"149.8KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4940,4937,4938&name=41st annual JP Morgan Healthcare Conference","openInNewWindowText":null}},{"itemId":8191,"headline":"Evercore ISI HealthCONx Conference ","introText":"Deborah Waterhouse, Chief Executive Officer of ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D at ViiV Healthcare, discussed the progress being made in HIV innovation during a fireside chat at the Evercore ISI HealthCONx Conference Wednesday, November 30th, 1pm UK / 8:00am ET.
","image":{"src":"/media/sedfczop/deborah-and-kim.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebce79e1b0","alt":"Deborah and Kim headshots","darkModeSrc":"/media/sedfczop/deborah-and-kim.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebce79e1b0"},"imageOverlayText":"","imageCaption":"","date":"30 November 2022","links":[{"text":"Listen to the webcast","href":"https://wsw.com/webcast/evercore29/register.aspx?conf=evercore29&page=gsk&url=https://wsw.com/webcast/evercore29/gsk/2175870","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8192,"headline":"Jefferies London Healthcare Conference","introText":"David Redfern, Chief Strategy Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, 16 November 2022 at 09:45 GMT.
","image":{"src":"/media/vk5kqg4c/gskh_04_2022_port_david_02_hess.jpg?rxy=0.50886075949367093,0.35858585858585856&width=900&height=600&format=webp&quality=100&v=1dba2ebb05709b0","alt":"David Redfern","darkModeSrc":"/media/vk5kqg4c/gskh_04_2022_port_david_02_hess.jpg?rxy=0.50886075949367093,0.35858585858585856&width=900&height=600&format=webp&quality=50&v=1dba2ebb05709b0"},"imageOverlayText":"","imageCaption":"","date":"16 November 2022","links":[{"text":"Listen to the webcast","href":"https://wsw.com/webcast/jeff255/register.aspx?conf=jeff255&page=gsk&url=https://wsw.com/webcast/jeff255/gsk/1701459","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8189,"headline":"Response to Investor Forum Letter","introText":"GSK’s response to an Investor Forum letter, regarding GSK’s redefined operating model post-Demerger.
","image":{"src":"/media/klagpt2g/sir-jonathan-symonds-2.jpeg?rxy=0.6283333333333333,0.18639053254437871&width=900&height=600&format=webp&quality=100&v=1dba2ebaff33ed0","alt":"Sir Jonathan Symonds","darkModeSrc":"/media/klagpt2g/sir-jonathan-symonds-2.jpeg?rxy=0.6283333333333333,0.18639053254437871&width=900&height=600&format=webp&quality=50&v=1dba2ebaff33ed0"},"imageOverlayText":"","imageCaption":"","date":"28 October 2022","links":[{"name":"GSK’s response to an Investor Forum letter","url":"/media/mssgzi3n/gsk-response-to-mr-andy-griffiths-the-investor-forum-letter.pdf","fileExtension":"PDF","fileSize":"232.4KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":null},{"itemId":8193,"headline":"Investor science event: Getting ahead of respiratory syncytial virus in older adults","introText":"After presenting the positive AReSVi-006 pivotal phase III results for our RSV (respiratory syncytial virus) older adults vaccine candidate at IDWeek 2022, GSK management hosted an investor science event on 21 October 2022.
","image":{"src":"/media/x3zob3rp/gsk_rsv_updated_close_still_6k_cmyk.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebd1eac580","alt":"RSV science image","darkModeSrc":"/media/x3zob3rp/gsk_rsv_updated_close_still_6k_cmyk.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebd1eac580"},"imageOverlayText":"","imageCaption":"","date":"21 October 2022","links":[{"text":"Listen to the webcast","href":"https://www.investis-live.com/gsk/6346d81f3bb8290c00a4e48c/qergq","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"},{"name":"GSK RSV Investor Science Event ID Week 2022","url":"/media/rsrmvfku/gsk-rsv-investor-science-event-id-week-2022.pdf","fileExtension":"PDF","fileSize":"1.6MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"GSK RSV Older Adults Investor Briefing Document","url":"/media/hiffccnt/gsk-rsv-older-adults-investor-briefing-document-oct-2022.pdf","fileExtension":"PDF","fileSize":"1.5MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"GSK Investor Science Event - Transcript","url":"/media/erxnlssn/gsk-investor-science-event-21oct22-transcript.pdf","fileExtension":"PDF","fileSize":"213.9KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--view"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4932,4934,4933&name=Investor science event: Getting ahead of respiratory syncytial virus in older adults","openInNewWindowText":null}},{"itemId":8194,"headline":"BofA 2022 Global Healthcare Conference","introText":"Emma Walmsley, CEO, participated in a fireside chat at the BofA Global Healthcare Conference on Friday 16 September at 0815 BST.
","image":{"src":"/media/ixfplhy0/gskh_05_2022_port_emma_04_hess.jpg?rxy=0.39166666666666666,0.599406528189911&width=900&height=600&format=webp&quality=100&v=1dba2ebcba0f820","alt":"Emma Walmsley in a blue dress ","darkModeSrc":"/media/ixfplhy0/gskh_05_2022_port_emma_04_hess.jpg?rxy=0.39166666666666666,0.599406528189911&width=900&height=600&format=webp&quality=50&v=1dba2ebcba0f820"},"imageOverlayText":"","imageCaption":"","date":"16 September 2022","links":[{"text":"Watch the webcast","href":"https://bofa.veracast.com/webcasts/bofa/globalhealthcareuk2022/idxD2o25.cfm","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8195,"headline":"Citi 17th Annual BioPharma Conference","introText":"Roger Connor, President Global Vaccines & Global Health and Phil Dormitzer, SVP, Head of Vaccines R&D joined Andrew Baum in a fireside chat at Citi’s 17th Annual BioPharma Conference which took place Wednesday, September 7 at 1:50pm ET/6:50pm UK.
","image":{"src":"/media/xyhdptld/roger-and-phil.png?width=900&height=600&format=webp&quality=100&v=1dba2ebce1ec960","alt":"Roger Connor and Phil Dormitzer","darkModeSrc":"/media/xyhdptld/roger-and-phil.png?width=900&height=600&format=webp&quality=50&v=1dba2ebce1ec960"},"imageOverlayText":"","imageCaption":"","date":"07 September 2022","links":[{"text":"Watch the webcast","href":"https://www.veracast.com/webcasts/citigroup/biopharma2022/7lva92.cfm","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8245,"headline":"dbAccess Global Consumer Conference 2022","introText":"Tobias Hestler, CFO GSK Consumer Healthcare participated in a fireside chat at the dB Access Global Consumer Conference on 14th June 2022 at 14:45pm BST (15:45pm CEST, 9:45am EDT).
\r\n","image":{"src":"/media/5nxjmx5y/662718_gsk_tobias_hestler_01_head_500px-ubs-global-consumer-and-retail-conference-2022.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebceadc2f0","alt":"Tobias Hestler","darkModeSrc":"/media/5nxjmx5y/662718_gsk_tobias_hestler_01_head_500px-ubs-global-consumer-and-retail-conference-2022.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebceadc2f0"},"imageOverlayText":"","imageCaption":"","date":"14 June 2022","links":[{"text":"Watch the webcast","href":"https://kvgo.com/deutsche-bank/glaxo-smith-kline-plc-june-2022","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8196,"headline":"Goldman Sachs 43rd Annual Global Healthcare Conference","introText":"
Deborah Waterhouse, CEO, ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D, ViiV Healthcare, discussed progress being made in the HIV space during a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference, Monday, June 13th at 10:00pm UK / 5:00pm ET
","image":{"src":"/media/uqhc0knu/deborah-kim-viiv-306x172.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebce899920","alt":"Deborah Kim","darkModeSrc":"/media/uqhc0knu/deborah-kim-viiv-306x172.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebce899920"},"imageOverlayText":"","imageCaption":"","date":"13 June 2022","links":[{"text":"Watch the webcast","href":"https://kvgo.com/gs/glaxo-smith-kline-june-2022","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8244,"headline":"UBS Global Healthcare Conference 2022","introText":"Dr. Kimberly Smith, Head of R&D, ViiV Healthcare, discussed progress being made in HIV innovation during a fireside chat at the UBS Global Healthcare Conference on Tuesday, May 24th at 2:15pm UK / 9:15am ET.
","image":{"src":"/media/wmohq2hq/gsk_k_smith_0298-1.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd0058ac0","alt":"Lady smiling","darkModeSrc":"/media/wmohq2hq/gsk_k_smith_0298-1.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd0058ac0"},"imageOverlayText":"","imageCaption":"","date":"24 May 2022","links":[{"text":"Watch the webcast","href":"https://kvgo.com/ubs-global-healthcare-2022/glaxosmithkline-plc-may","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8226,"headline":"JPMorgan CEO Consumer Staples fireside chat series","introText":"Brian McNamara, CEO Designate of Consumer Healthcare, participated in a fireside chat with JPMorgan analyst Celine Pannuti as part of her series of discussions with consumer staples CEOs. In the conversation Brian discussed the growth outlook across various consumer health categories, recent innovation trends and progress towards becoming a standalone company.
","image":{"src":"/media/bdokxuoe/662718_gsk_brian_mcnamara_02_head_500px-jpmorgan-ceo-consumer-staples-fireside-chat-series.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebcf5c2b60","alt":"Brian Mcnamara","darkModeSrc":"/media/bdokxuoe/662718_gsk_brian_mcnamara_02_head_500px-jpmorgan-ceo-consumer-staples-fireside-chat-series.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebcf5c2b60"},"imageOverlayText":"","imageCaption":"","date":"20 May 2022","links":[{"text":"Watch the webcast. Access code: 368408","href":"https://ige.netroadshow.com/replay/7653/european-consumer-ceo-fireside-chat--haleon--brian-mcnamara/","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8243,"headline":"ESG Investor Education Event (Environment)","introText":"Claire Lund, Vice President Environmental Sustainability, hosted our first ESG Investor Education Event focusing on our environment strategy, 5 April 2022 at 15:00 BST / 10:00 EDT.
","image":{"src":"/media/zpqf1cre/claire-lund-photo-esg-investor-education-event-environment.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebce99ecd0","alt":"Claire Lund","darkModeSrc":"/media/zpqf1cre/claire-lund-photo-esg-investor-education-event-environment.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebce99ecd0"},"imageOverlayText":"","imageCaption":"","date":"05 April 2022","links":[{"text":"Watch the replay","href":"https://www.youtube.com/watch?v=iB7SzptcvS8&feature=youtu.be","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"},{"name":"Presentation","url":"/media/inmnodqs/gsk_investoreducationevent_20220405-1.pdf","fileExtension":"PDF","fileSize":"3.4MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Transcript","url":"/media/roxgr4h5/gsk-investoreducation-5apr22_transcript.pdf","fileExtension":"PDF","fileSize":"228.8KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4910,4911&name=ESG Investor Education Event (Environment)","openInNewWindowText":null}},{"itemId":8242,"headline":"UBS Global Consumer and Retail Conference 2022","introText":"Tobias Hestler, CFO Designate of Consumer Healthcare, participated in a fireside chat at the UBS Global Consumer and Retail Conference hosted by UBS analyst Guillaume Delmas.
","image":{"src":"/media/5nxjmx5y/662718_gsk_tobias_hestler_01_head_500px-ubs-global-consumer-and-retail-conference-2022.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebceadc2f0","alt":"Tobias Hestler","darkModeSrc":"/media/5nxjmx5y/662718_gsk_tobias_hestler_01_head_500px-ubs-global-consumer-and-retail-conference-2022.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebceadc2f0"},"imageOverlayText":"","imageCaption":"","date":"09 March 2022","links":[{"text":"Watch the webcast","href":"https://kvgo.com/ubs/glaxo-smith-kline-plc-march-2022","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8241,"headline":"Cowen 42nd Annual Health Care Conference","introText":"Hal Barron, Chief Scientific Officer and President R&D, discussed the progress GSK is making in R&D during a fireside chat at the Cowen 42nd Annual Health Care Conference taking place virtually on Monday, 7 March 2022 at 4:10pm UK/11:10pm ET.
","image":{"src":"/media/axcjh0m1/halbarron-cowen-42nd-annual-health-care-conference.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd1266410","alt":"Halbarron Cowen","darkModeSrc":"/media/axcjh0m1/halbarron-cowen-42nd-annual-health-care-conference.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd1266410"},"imageOverlayText":"","imageCaption":"","date":"07 March 2022","links":[{"text":"Watch the webcast","href":"https://wsw.com/webcast/cowen108/register.aspx?conf=cowen108&page=gsk&url=https://wsw.com/webcast/cowen108/gsk/1851273","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8240,"headline":"GSK Consumer Healthcare Capital Markets Day","introText":"GSK's Consumer Healthcare Capital Markets Day took place on Monday 28 February 2022. This event provided details on our strategy, brands, capabilities and operations, as well as detailed financial information and future growth ambitions ahead of the proposed listing on the London Stock Exchange following the anticipated demerger from GSK mid-2022.
","image":{"src":"/media/ss4jxmo4/power-brands-with-logo-gsk-consumer-healthcare-capital-markets-day.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd0492370","alt":"Power Brands With Logo GSK Consumer Healthcare Capital Markets Day","darkModeSrc":"/media/ss4jxmo4/power-brands-with-logo-gsk-consumer-healthcare-capital-markets-day.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd0492370"},"imageOverlayText":"","imageCaption":"","date":"28 February 2022","links":[{"name":"Haleon Capital Markets Day All Presentation Slides","url":"/media/t30f0rmg/haleon-capital-markets-day-all-presentation-slides.pdf","fileExtension":"PDF","fileSize":"12.4MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Haleon Capital Markets Day Full Presentation Transcript","url":"/media/zy3d3sj3/haleon-capital-markets-day-full-presentation-transcript.pdf","fileExtension":"PDF","fileSize":"307.3KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Haleon Factsheet","url":"/media/uk4janzp/haleon-factsheet.pdf","fileExtension":"PDF","fileSize":"960.4KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"text":"Capital Markets Day Webcast platform","href":"https://gskch.connectid.cloud/","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4912,4913,4915&name=GSK Consumer Healthcare Capital Markets Day","openInNewWindowText":null}},{"itemId":8239,"headline":"FCLT Global presents “Investing in Healthcare Innovations: A Case Study of Multi-stakeholder Capitalism in Practice\"","introText":"Roger Connor, President Global Vaccines & Global Health, particpated in a panel hosted by FCLT Global on Thursday, February 10th at 8:00am ET/1:00pm GMT. The panel focused on navigating the complexity of long-term strategies and investment since financing healthcare advancements, and particularly vaccine development, became central priority with the onset of COVID19.
","image":{"src":"/media/lnhhxmtv/roger-1118x630-fclt-global-presents-investing-in-healthcare-innovations-a-case-study-of-multi-stakeholder-capitalism-in-practice.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd08f5430","alt":"Roger Connor","darkModeSrc":"/media/lnhhxmtv/roger-1118x630-fclt-global-presents-investing-in-healthcare-innovations-a-case-study-of-multi-stakeholder-capitalism-in-practice.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd08f5430"},"imageOverlayText":"","imageCaption":"","date":"10 February 2022","links":[{"text":"Watch the Webinar","href":"https://www.fcltglobal.org/resource/healthcare-innovations-webinar/","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":null},{"itemId":8238,"headline":"JP Morgan Healthcare Conference 2022","introText":"Emma Walmsley, Chief Executive Officer, presented at the 40th annual JP Morgan Healthcare Conference on Tuesday 11 January at 07:30-08:10am ET / 12:30-13:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion.
","image":{"src":"/media/lrpixwp5/emma-walmsley-gold-jp-morgan-healthcare-conference-2022.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd02a29c0","alt":"Emma Walmsley","darkModeSrc":"/media/lrpixwp5/emma-walmsley-gold-jp-morgan-healthcare-conference-2022.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd02a29c0"},"imageOverlayText":"","imageCaption":"","date":"11 January 2022","links":[{"text":"Listen to the audio","href":"https://jpmorgan.metameetings.net/events/healthcare22/sessions/39843-glaxosmithkline/webcast","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"},{"name":"JP Morgan Healthcare Conference Presentation","url":"/media/b04ksiwl/jp-morgan-healthcare-conference-presentation.pdf","fileExtension":"PDF","fileSize":"735.4KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"JP Morgan Healthcare conference transcript","url":"/media/4qbnxirl/jpm-gsk-transcript-11-jan-2022.pdf","fileExtension":"PDF","fileSize":"448.6KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4914,4916&name=JP Morgan Healthcare Conference 2022","openInNewWindowText":null}},{"itemId":8237,"headline":"Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference","introText":"Emma Walmsley, Chief Executive Officer, participated in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference: A View from the Top, on Thursday, 6 January 2022 at 8:00am ET.
","image":{"src":"/media/xbmbl25r/ascr1509_cc_resized-bofa-2021-global-healthcare-conference.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd0edeef0","alt":"Dame Emma Walmsley","darkModeSrc":"/media/xbmbl25r/ascr1509_cc_resized-bofa-2021-global-healthcare-conference.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd0edeef0"},"imageOverlayText":"","imageCaption":"","date":"06 January 2022","links":[],"downloadAllLink":null},{"itemId":8236,"headline":"Morgan Stanley ESG Insights Conference 2021","introText":"Harmony Garges, SVP and Chief Medical Officer ViiV Healthcare, presented at the virtual Morgan Stanley ESG Insights Conference and provided an overview of ViiV’s mission to leave no person living with HIV behind and how it aligns with ViiV’s ESG efforts.
","image":{"src":"/media/hfud1vky/harmony-garges-morgan-stanley-esg-insights-conference-2021.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd07c1a50","alt":"Lady at ESG Insights Conference 2021","darkModeSrc":"/media/hfud1vky/harmony-garges-morgan-stanley-esg-insights-conference-2021.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd07c1a50"},"imageOverlayText":"","imageCaption":"","date":"02 December 2021","links":[{"name":"Morgan Stanley ESG Insights Conference presentation","url":"/media/lhrh2viz/ms-esg-garges_draft_1dec21_final.pdf","fileExtension":"PDF","fileSize":"3.4MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":null},{"itemId":8235,"headline":"Redburn CEO conference 2021","introText":"Brian McNamara, CEO of GSK Consumer Healthcare, participated in a virtual fireside chat at the 2021 Redburn CEO Conference. He provided an overview of our business and broader industry.
","image":{"src":"/media/5nxc154b/brian-mcnamara-gsk-redburn-ceo-conference-2021.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd1163770","alt":"Brian Mcnamara","darkModeSrc":"/media/5nxc154b/brian-mcnamara-gsk-redburn-ceo-conference-2021.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd1163770"},"imageOverlayText":"","imageCaption":"","date":"01 December 2021","links":[],"downloadAllLink":null},{"itemId":8234,"headline":"Meet GSK management: getting ahead of HIV","introText":"GSK hosted a ‘Meet GSK management’ event on 29 November 2021 at 15:00 GMT / 10:00 EST.
","image":{"src":"/media/r1hpl4oz/david-deborah-kim-meet-gsk-management-getting-ahead-of-hiv.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebcfaf0650","alt":"David Deborah Kim","darkModeSrc":"/media/r1hpl4oz/david-deborah-kim-meet-gsk-management-getting-ahead-of-hiv.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebcfaf0650"},"imageOverlayText":"","imageCaption":"","date":"29 November 2021","links":[{"name":"Getting ahead of HIV presentation","url":"/media/0z5pips4/gsk_getting_ahead_of_hiv-evnt-presentation-29-nov-21.pdf","fileExtension":"PDF","fileSize":"10.7MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Getting ahead of HIV transcript","url":"/media/o2yhodzi/gsk-hiv-event-transcript-29nov21.pdf","fileExtension":"PDF","fileSize":"194.2KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"text":"Webcast registration","href":"https://www.investis-live.com/gsk/618a4cac75c49013003814bb/bdft","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4895,4896&name=Meet GSK management: getting ahead of HIV","openInNewWindowText":null}},{"itemId":8233,"headline":"UBS European Conference 2021","introText":"Tobias Hestler, CFO GSK Consumer Healthcare, participated in a virtual fireside chat at the UBS European Conference hosted by analyst Guillaume Delmas.
","image":{"src":"/media/1jggtsjw/tobias-hestler-our-leaders-328x202-bernstein-annual-pan-european-strategic-decisions-conference.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebcf12ed60","alt":"Tobias Hestler","darkModeSrc":"/media/1jggtsjw/tobias-hestler-our-leaders-328x202-bernstein-annual-pan-european-strategic-decisions-conference.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebcf12ed60"},"imageOverlayText":"","imageCaption":"","date":"09 November 2021","links":[],"downloadAllLink":null},{"itemId":8232,"headline":"Investor science event: ASN Kidney Week 2021","introText":"GSK held an investor science event for daprodustat’s ASCEND Phase III programme at 12 noon EST/ 5pm GMT on 7 November 2021.
","image":{"src":"/media/ppidcvl4/hal-barron-luke-miels-306-x-172.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebcec01270","alt":"Hal Barron Luke Miels","darkModeSrc":"/media/ppidcvl4/hal-barron-luke-miels-306-x-172.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebcec01270"},"imageOverlayText":"","imageCaption":"","date":"07 November 2021","links":[{"text":"Register to the webcast","href":"https://www.investis-live.com/gsk/616d98332a563a1200a6af57/etad","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"},{"name":"ASN 2021 presentation","url":"/media/ttnngwup/20211105-prsn-asn-2021-website-slides-only.pdf","fileExtension":"PDF","fileSize":"2.5MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"ASN 2021 transcript","url":"/media/me2nlqzq/gsk-investorevent-transcript-7nov21.pdf","fileExtension":"PDF","fileSize":"155.1KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4897,4898&name=Investor science event: ASN Kidney Week 2021","openInNewWindowText":null}},{"itemId":8231,"headline":"The Investor Forum","introText":"Sir Jonathan Symonds, Chairman, and Manvinder Singh Banga, Senior Independent Non-Executive Director, participated in an Investor Forum meeting on Thursday 7 October 2021.
","image":{"src":"/media/exllbj5f/jon_vindi-the-investor-forum.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebced15080","alt":"Jon Vindi","darkModeSrc":"/media/exllbj5f/jon_vindi-the-investor-forum.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebced15080"},"imageOverlayText":"","imageCaption":"","date":"07 October 2021","links":[{"name":"Presentation slides","url":"/media/mdecqxcu/investor-forum-slides.pdf","fileExtension":"PDF","fileSize":"405.8KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":null},{"itemId":8230,"headline":"Guggenheim 2nd Annual Vaccine and Infectious Disease Day","introText":"Rino Rappuoli, Senior Vice President Global Head of Vaccines R&D, participated in a fireside chat at Guggenheim’s 2nd Annual Vaccine and Infectious Disease Day which took place on Wednesday 6 October 2021 at 1:00pm ET.
","image":{"src":"/media/0ojfre14/rino-rappuoli-guggenheim-2nd-annual-vaccine-and-infectious-disease-day.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd104d250","alt":"Rino Rappuoli","darkModeSrc":"/media/0ojfre14/rino-rappuoli-guggenheim-2nd-annual-vaccine-and-infectious-disease-day.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd104d250"},"imageOverlayText":"","imageCaption":"","date":"06 October 2021","links":[],"downloadAllLink":null},{"itemId":8229,"headline":"Bernstein Annual Pan European Strategic Decisions Conference","introText":"Tobias Hestler, CFO for GSK Consumer Healthcare participated in a virtual fireside chat at the Bernstein Annual Pan European Strategic Decisions Conference.
","image":{"src":"/media/0kshuold/tobias-hestler-our-leaders-328x202-bernstein-annual-pan-european-strategic-decisions-conference.jpg?width=900&height=600&format=webp&quality=100&v=1dba2ebcefa8360","alt":"Tobias Hestler","darkModeSrc":"/media/0kshuold/tobias-hestler-our-leaders-328x202-bernstein-annual-pan-european-strategic-decisions-conference.jpg?width=900&height=600&format=webp&quality=50&v=1dba2ebcefa8360"},"imageOverlayText":"","imageCaption":"","date":"22 September 2021","links":[],"downloadAllLink":null},{"itemId":8228,"headline":"BofA 2021 Global Healthcare Conference","introText":"Emma Walmsley, CEO, participated in a fireside chat at the BofA Global Healthcare Conference on Friday 17 September at 0815 BST.
","image":{"src":"/media/xbmbl25r/ascr1509_cc_resized-bofa-2021-global-healthcare-conference.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd0edeef0","alt":"Dame Emma Walmsley","darkModeSrc":"/media/xbmbl25r/ascr1509_cc_resized-bofa-2021-global-healthcare-conference.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd0edeef0"},"imageOverlayText":"","imageCaption":"","date":"17 September 2021","links":[],"downloadAllLink":null},{"itemId":8227,"headline":"Barclay’s Global Consumer Staples conference","introText":"Brian McNamara, CEO GSK Consumer Healthcare, joined a virtual fireside chat hosted by Barclay’s analyst, Iain Simpson. He provided an overview of the Consumer Healthcare business and our category leading brands.
","image":{"src":"/media/h3mcevqj/brian-mcnamara-barclay-s-global-consumer-staples-conference.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebcf749560","alt":"Brian Mcnamara","darkModeSrc":"/media/h3mcevqj/brian-mcnamara-barclay-s-global-consumer-staples-conference.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebcf749560"},"imageOverlayText":"","imageCaption":"","date":"10 September 2021","links":[],"downloadAllLink":null},{"itemId":8225,"headline":"Citi 16th Annual Biopharma Conference","introText":"Dr. Kimberly Smith, Head of R&D, ViiV Healthcare participated in a fireside chat at Citi’s 16th Annual Biopharma Conference taking place on Thursday 9 September 2021 at 18:25 UK / 1:25pm EDT. Dr. Smith provided an update on ViiV Healthcare’s progress in advancing HIV science and R&D.
","image":{"src":"/media/wmohq2hq/gsk_k_smith_0298-1.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd0058ac0","alt":"Lady smiling","darkModeSrc":"/media/wmohq2hq/gsk_k_smith_0298-1.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd0058ac0"},"imageOverlayText":"","imageCaption":"","date":"09 September 2021","links":[],"downloadAllLink":null},{"itemId":8224,"headline":"Guggenheim’s Biopharma Strategy Series","introText":"Hal Barron, Chief Scientific Officer and President R&D, joined a virtual fireside chat hosted by Guggenheim analyst Seamus Fernandez at Guggenheim’s Biopharma Strategy Series.
\nThe event, 'Biopharma's Next Decade: Views from the Top on Global Strategy and Innovation' took place Tuesday, 29 June 2021 at 19:00 BST / 14:00 EDT, during which he provided an update on the progress GSK is making in R&D.
","image":{"src":"/media/axcjh0m1/halbarron-cowen-42nd-annual-health-care-conference.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd1266410","alt":"Halbarron Cowen","darkModeSrc":"/media/axcjh0m1/halbarron-cowen-42nd-annual-health-care-conference.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd1266410"},"imageOverlayText":"","imageCaption":"","date":"29 June 2021","links":[],"downloadAllLink":null},{"itemId":8223,"headline":"New GSK Investor update","introText":"Emma Walmsley, CEO, and other members of CET hosted a virtual investor update at 14:00-17:30 BST on Wednesday 23 June. The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.
","image":{"src":"/media/xbmbl25r/ascr1509_cc_resized-bofa-2021-global-healthcare-conference.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd0edeef0","alt":"Dame Emma Walmsley","darkModeSrc":"/media/xbmbl25r/ascr1509_cc_resized-bofa-2021-global-healthcare-conference.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd0edeef0"},"imageOverlayText":"","imageCaption":"","date":"23 June 2021","links":[{"name":"Presentation slides","url":"/media/yd1f1rpu/gsk-investor-update_23-06-21.pdf","fileExtension":"PDF","fileSize":"7.9MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Presentation transcript","url":"/media/wksd3smy/presentation-transcript.pdf","fileExtension":"PDF","fileSize":"269.5KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Q&A transcript","url":"/media/ca1jupwo/qa-transcript.pdf","fileExtension":"PDF","fileSize":"150.3KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Epidemiology data","url":"/media/rjtd4l3v/epidemiology-data.pdf","fileExtension":"PDF","fileSize":"3.3MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"Clinical trials summary","url":"/media/xwqdtooo/clinical-trials-summary.pdf","fileExtension":"PDF","fileSize":"3.5MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"text":"Link to the event webcast","href":"https://gsk.connectid.cloud/","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4907,4906,4904,4908,4903&name=New GSK Investor update","openInNewWindowText":null}},{"itemId":8222,"headline":"Exane BNP Paribas 23rd European CEO Conference","introText":"Brian McNamara, CEO, GSK Consumer Healthcare, presented at the conference and provided an introduction to GSK Consumer Healthcare and outlined our purpose, strategy, category-leading brands and capabilities, as well as an overview of the consumer healthcare sector.
","image":{"src":"/media/5nxc154b/brian-mcnamara-gsk-redburn-ceo-conference-2021.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd1163770","alt":"Brian Mcnamara","darkModeSrc":"/media/5nxc154b/brian-mcnamara-gsk-redburn-ceo-conference-2021.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd1163770"},"imageOverlayText":"","imageCaption":"","date":"10 June 2021","links":[{"name":"Exane June 21 Show File Vf","url":"/media/0wyaagyf/exane-june-21-show-file-vf.pdf","fileExtension":"PDF","fileSize":"2.5MB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":null},{"itemId":8221,"headline":"CECP Biopharma Investor Forum","introText":"Emma Walmsley, CEO, presented at CECP’s Biopharma Investor Forum on Tuesday 8 June at 8:40 EST/13:40 BST, during which she provided an overview on our approach to ESG. The presentation was followed by a moderated Q&A session.
","image":{"src":"/media/rwtblo2t/emma-walmsley-1.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd0baa9f0","alt":"Dame Emma Walmsley","darkModeSrc":"/media/rwtblo2t/emma-walmsley-1.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd0baa9f0"},"imageOverlayText":"","imageCaption":"","date":"08 June 2021","links":[{"name":"CECP presentation slides","url":"/media/lkjlhdh5/cecp-presentation-070621-pdf-version-of-slides.pdf","fileExtension":"PDF","fileSize":"505.4KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"CECP presentation script","url":"/media/msgpdekp/script-word-version-070621-pdf.pdf","fileExtension":"PDF","fileSize":"154.6KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4900,4901&name=CECP Biopharma Investor Forum","openInNewWindowText":null}},{"itemId":8220,"headline":"Barclays Global Healthcare Conference 2021","introText":"Deborah Waterhouse, CEO of ViiV Healthcare, participated in a fireside chat at the Barclays Global Healthcare Conference on Wednesday, March 10 at 8:35am ET/1:35pm GMT, during which she provided an update on the progress GSK is making in the HIV space.
","image":{"src":"/media/mqojwrtq/dw_gskcom_biog_page_1118x630.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd0a5c260","alt":"Deborah Waterhouse","darkModeSrc":"/media/mqojwrtq/dw_gskcom_biog_page_1118x630.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd0a5c260"},"imageOverlayText":"","imageCaption":"","date":"10 March 2021","links":[],"downloadAllLink":null},{"itemId":8219,"headline":"Cowen 41st Annual Health Care Conference","introText":"Hal Barron, Chief Scientific Officer and President R&D, participated in a fireside chat at the Cowen 41st Annual Health Care Conference on Monday, March 1 2021 at 5:20pm GMT /12:20pm ET, during which he discussed updates on the progress GSK is making in R&D.
","image":{"src":"/media/axcjh0m1/halbarron-cowen-42nd-annual-health-care-conference.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd1266410","alt":"Halbarron Cowen","darkModeSrc":"/media/axcjh0m1/halbarron-cowen-42nd-annual-health-care-conference.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd1266410"},"imageOverlayText":"","imageCaption":"","date":"01 March 2021","links":[],"downloadAllLink":null},{"itemId":8218,"headline":"Guggenheim Healthcare Talks 2021","introText":"Axel Hoos, GSK Senior Vice-President Oncology R&D, joined a Fireside Chat with Seamus Fernandez at the Guggenheim Healthcare Talks 2021 Oncology Days, Thursday, February 11, at 10AM ET, where the duo discussed GSK Oncology R&D progress.
","image":{"src":"/media/xc3du2eu/axel-hoos.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd0611840","alt":"Axel Hoos","darkModeSrc":"/media/xc3du2eu/axel-hoos.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd0611840"},"imageOverlayText":"","imageCaption":"","date":"11 February 2021","links":[],"downloadAllLink":null},{"itemId":8217,"headline":"39th annual JP Morgan Virtual Healthcare Conference","introText":"Hal Barron, Chief Scientific Officer and President R&D, presented at the 39th annual JP Morgan Virtual Healthcare Conference on Tuesday 12 January at 10:50-11:30am ET / 15:50-16:30 GMT. The presentation was followed by a Q&A session.
","image":{"src":"/media/axcjh0m1/halbarron-cowen-42nd-annual-health-care-conference.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd1266410","alt":"Halbarron Cowen","darkModeSrc":"/media/axcjh0m1/halbarron-cowen-42nd-annual-health-care-conference.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd1266410"},"imageOverlayText":"","imageCaption":"","date":"11 January 2021","links":[{"name":"Gsk Jpm 2021 Final 12012021","url":"/media/l1anvqyf/gsk_jpm_2021_final_12012021.pdf","fileExtension":"PDF","fileSize":"689.9KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"},{"name":"39Th Annual Jp Morgan Virtual Healthcare Conference Transcript","url":"/media/pdkkzosz/39th-annual-jp-morgan-virtual-healthcare-conference_transcript.pdf","fileExtension":"PDF","fileSize":"125.9KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":{"text":"Download all","href":"/umbraco/api/DownloadAll/Zip/?fileIds=4902,4918&name=39th annual JP Morgan Virtual Healthcare Conference","openInNewWindowText":null}},{"itemId":8216,"headline":"Goldman Sachs 13th Annual Healthcare Unscripted CEOs Conference","introText":"Emma Walmsley, CEO, hosted a fireside chat at the Goldman Sachs 13th annual healthcare unscripted CEOs conference on Tuesday 5 January at 12:00 GMT
","image":{"src":"/media/rwtblo2t/emma-walmsley-1.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebd0baa9f0","alt":"Dame Emma Walmsley","darkModeSrc":"/media/rwtblo2t/emma-walmsley-1.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebd0baa9f0"},"imageOverlayText":"","imageCaption":"","date":"05 January 2021","links":[],"downloadAllLink":null},{"itemId":8215,"headline":"Morgan Stanley ESG Insights Conference","introText":"Phil Thomson, President Global Affairs, hosted a fireside chat at the Morgan Stanley ESG Insights Conference on Wednesday, 9 December 2020 at 15:25 GMT / 10:25am EST.
","image":{"src":"/media/k5ojxe0p/phil-thomson-gsk.jpeg?width=900&height=600&format=webp&quality=100&v=1dba2ebcf295b90","alt":"Phil Thomson","darkModeSrc":"/media/k5ojxe0p/phil-thomson-gsk.jpeg?width=900&height=600&format=webp&quality=50&v=1dba2ebcf295b90"},"imageOverlayText":"","imageCaption":"","date":"09 December 2020","links":[{"text":"Morgan Stanley ESG Insights Conference webcast","href":"https://morganstanley.webcasts.com/starthere.jsp?ei=1409569&tp_key=db07460803","target":"_blank","openInNewWindowText":"Opens in a new window","type":"href","icon":"icon--external"},{"name":"Morgan Stanley ESG Conference presentation","url":"/media/4dmnau1h/gsk-ms-esg-conf-2020-12-09.pdf","fileExtension":"PDF","fileSize":"366.3KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window","icon":"icon--download"}],"downloadAllLink":null}]},"captions":{"showMore":"Show more","mostRecent":"Most recent","mostRelevant":"Most relevant","search":"Search","download":"Download","resetSearch":"Reset search","clear":"Clear all","noResults":"We’re sorry, we can’t seem to find any search results matching your criteria.","resultsAvailable":"Results available","cancel":"Cancel","apply":"Apply","nowPlaying":"Now playing","paginationAriaLabel":"Pagination","previous":"previous","previousAriaLabel":"Go to previous page","next":"next","nextAriaLabel":"Go to next page","goToPageAriaLabel":"Go to page ##PAGE##","currentPageAriaLabel":"Page","numberOfResultsPerPage":"Number of results per page","playVideo":"Play video {title}","filterBy":"Filter By:","sortBy":"Sort By:","select":"Select","filterByYear":"Filter by year"},"id":6298,"docCheckLogout":null,"pageType":"blockListingPage","languageCode":"en-GB","theme":"light","breadcrumb":{"ariaLabel":"Breadcrumb","links":[{"text":"Home","href":"/en-gb/","openInNewWindowText":null},{"text":"Investors","href":"/en-gb/investors/","openInNewWindowText":null},{"text":"Speeches and presentations","href":"/en-gb/investors/speeches-and-presentations/","openInNewWindowText":null}]},"pageName":"Speeches and presentations","topNav":{"homeLink":{"text":"GSK Homepage","href":"/en-gb/","openInNewWindowText":null},"topBar":{"currentLocation":{"isGlobal":true,"text":"Global"},"languageSelector":{"currentLanguage":null,"currentLanguageMobile":null,"selectableLanguages":[]},"darkModeSwitch":{"text":"Dark mode","tooltipText":"Switch to dark mode to head towards a more sustainable world together. More info
"},"globalSiteLink":null,"locationSelector":{"text":"Change location","href":"/en-gb/locations/","openInNewWindowText":null},"healthCareLink":{"text":"Healthcare professionals","href":"https://www.gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"contactUs":{"text":"Contact us","href":"/en-gb/contact-us/","openInNewWindowText":null},"search":"Search","backToMain":"Back to main","menu":"Menu","closeMenu":"Close menu","animationsToggleModel":{"enable":true,"activeText":"Pause video","inactiveText":"Play video"}},"nodes":[{"tooltip":null,"hasBorderRight":true,"title":"Behind the Science magazine","url":"/en-gb/behind-the-science-magazine/","nodes":[],"isActive":false,"promos":[]},{"tooltip":null,"hasBorderRight":false,"title":"Company","url":"/en-gb/company/","nodes":[{"title":"Purpose, strategy and culture","url":"/en-gb/company/purpose-strategy-and-culture/","nodes":[],"isActive":false},{"title":"Outstanding people","url":"/en-gb/company/outstanding-people/","nodes":[{"title":"Great place to work","url":"/en-gb/company/outstanding-people/great-place-to-work/","nodes":[],"isActive":false},{"title":"Meet our veterans","url":"/en-gb/company/outstanding-people/meet-our-veterans/","nodes":[],"isActive":false},{"title":"Working together","url":"/en-gb/company/outstanding-people/working-together/","nodes":[],"isActive":false},{"title":"My GSK story","url":"/en-gb/company/outstanding-people/my-gsk-story/","nodes":[],"isActive":false},{"title":"Innovating together","url":"/en-gb/company/outstanding-people/innovating-together/","nodes":[],"isActive":false}],"isActive":false},{"title":"GSK at a glance","url":"/en-gb/company/gsk-at-a-glance/","nodes":[],"isActive":false},{"title":"History and heritage","url":"/en-gb/company/history-and-heritage/","nodes":[],"isActive":false},{"title":"Board of Directors and Executive Committee","url":"/en-gb/company/board-of-directors-and-leadership-team/","nodes":[],"isActive":false},{"title":"Board information","url":"/en-gb/company/board-information/","nodes":[],"isActive":false},{"title":"Governance","url":"/en-gb/company/governance/","nodes":[{"title":"Committees","url":"/en-gb/company/governance/committees/","nodes":[],"isActive":false},{"title":"Shareholders","url":"/en-gb/company/governance/shareholders/","nodes":[],"isActive":false},{"title":"Sarbanes-Oxley Act 2002","url":"/en-gb/company/governance/sarbanes-oxley-act-2002/","nodes":[],"isActive":false},{"title":"Compliance","url":"/en-gb/company/governance/compliance/","nodes":[],"isActive":false}],"isActive":false},{"title":"Policy positions","url":"/en-gb/company/policy-positions/","nodes":[],"isActive":false},{"title":"Codes, standards and reports","url":"/en-gb/company/codes-standards-and-reports/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Our purpose, strategy and culture","image":{"src":"/media/vvwddvsg/gsk_tech_human_image_6k.jpg?rxy=0.56833333333333336,0.30177514792899407&width=329&height=185&format=webp&quality=100&v=1dba2ec0bc1e680","alt":"GSK Tech Human Image","darkModeSrc":"/media/vvwddvsg/gsk_tech_human_image_6k.jpg?rxy=0.56833333333333336,0.30177514792899407&width=329&height=185&format=webp&quality=50&v=1dba2ec0bc1e680"},"link":{"text":"FEATURED SECTION","href":"/en-gb/company/purpose-strategy-and-culture/","openInNewWindowText":null}},{"text":"Outstanding people","image":{"src":"/media/kgwp0dc5/sddefault-2.jpg?rxy=0.425,0.51807228915662651&width=329&height=185&format=webp&quality=100&v=1dba2eba773f3d0","alt":"Angeles sitting on a sofa in a pink shirt","darkModeSrc":"/media/kgwp0dc5/sddefault-2.jpg?rxy=0.425,0.51807228915662651&width=329&height=185&format=webp&quality=50&v=1dba2eba773f3d0"},"link":{"text":"FEATURED SECTION","href":"/en-gb/company/outstanding-people/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Innovation","url":"/en-gb/innovation/","nodes":[{"title":"Our leading scientists","url":"/en-gb/innovation/our-leading-scientists/","nodes":[{"title":"Dr Tony Wood","url":"/en-gb/innovation/our-leading-scientists/tony-wood/","nodes":[],"isActive":false},{"title":"Dr Sabine Luik","url":"/en-gb/innovation/our-leading-scientists/sabine-luik/","nodes":[],"isActive":false},{"title":"Dr Hesham Ahmed Abdullah","url":"/en-gb/innovation/our-leading-scientists/hesham-abdullah/","nodes":[],"isActive":false},{"title":"Dr Kaivan Khavandi","url":"/en-gb/innovation/our-leading-scientists/kaivan-khavandi/","nodes":[],"isActive":false},{"title":"Dr Christopher Austin","url":"/en-gb/innovation/our-leading-scientists/dr-christopher-austin/","nodes":[],"isActive":false}],"isActive":false},{"title":"Research and development approach","url":"/en-gb/innovation/research-and-development-approach/","nodes":[],"isActive":false},{"title":"Pipeline","url":"/en-gb/innovation/pipeline/","nodes":[],"isActive":false},{"title":"Therapeutic areas","url":"/en-gb/innovation/therapeutic-areas/","nodes":[{"title":"Respiratory, immunology and inflammation","url":"/en-gb/innovation/therapeutic-areas/respiratory-immunology-and-inflammation/","nodes":[],"isActive":false},{"title":"Oncology","url":"/en-gb/innovation/therapeutic-areas/oncology/","nodes":[],"isActive":false},{"title":"HIV","url":"/en-gb/innovation/therapeutic-areas/hiv/","nodes":[],"isActive":false},{"title":"Infectious diseases","url":"/en-gb/innovation/therapeutic-areas/infectious-diseases/","nodes":[],"isActive":false}],"isActive":false},{"title":"Tech","url":"/en-gb/innovation/technologies/","nodes":[],"isActive":false},{"title":"Clinical trials at GSK","url":"/en-gb/innovation/trials/","nodes":[{"title":"Provision of unapproved medicines for unmet medical needs","url":"/en-gb/innovation/trials/provision-of-unlicensed-medicines-for-unmet-medical-needs/","nodes":[],"isActive":false},{"title":"Data transparency","url":"/en-gb/innovation/trials/data-transparency/","nodes":[],"isActive":false},{"title":"Representative clinical studies","url":"/en-gb/innovation/trials/representative-clinical-studies/","nodes":[],"isActive":false}],"isActive":false},{"title":"Partnering with GSK","url":"/en-gb/innovation/partnerships/","nodes":[{"title":"Supported studies","url":"/en-gb/innovation/partnerships/supported-studies/","nodes":[],"isActive":false}],"isActive":false},{"title":"R&D locations","url":"/en-gb/innovation/rd-locations/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Behind the science magazine","image":{"src":"/media/ukvllwft/vaccine-manufacturing-production-line-2.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebb585f130","alt":"Scientist works in a futurist vaccine laboratory for GSK","darkModeSrc":"/media/ukvllwft/vaccine-manufacturing-production-line-2.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebb585f130"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/behind-the-science-magazine/","openInNewWindowText":null}},{"text":"Our leading scientists","image":{"src":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=329&height=185&format=webp&quality=100&v=1dc651e856734f0","alt":"Tony Wood","darkModeSrc":"/media/45khexa4/tony-16x9.jpg?rxy=0.5733215608441357,0.39891812701082546&width=329&height=185&format=webp&quality=50&v=1dc651e856734f0"},"link":{"text":"Featured section","href":"/en-gb/innovation/our-leading-scientists/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Products","url":"/en-gb/products/","nodes":[{"title":"Product areas","url":"/en-gb/products/our-product-areas/","nodes":[],"isActive":false},{"title":"Products A-Z","url":"/en-gb/products/products-a-z/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Innovation","image":{"src":"/media/jxkd3fld/web03-header-stvg_2_2022_port_5_hess_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebbe22d650","alt":"Lab technician leaning against wall","darkModeSrc":"/media/jxkd3fld/web03-header-stvg_2_2022_port_5_hess_nav.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebbe22d650"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/innovation/","openInNewWindowText":null}},{"text":"GSKPro for healthcare professionals ","image":{"src":"/media/xpibjmpq/navthumb_stvg_03_2022_port_32_eagle_orange-1.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebbe35c210","alt":"Two scientists on orange background","darkModeSrc":"/media/xpibjmpq/navthumb_stvg_03_2022_port_32_eagle_orange-1.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebbe35c210"},"link":{"text":"FEATURED WEBSITE","href":"https://gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":true,"title":"Responsibility","url":"/en-gb/responsibility/","nodes":[{"title":"Access","url":"/en-gb/responsibility/access/","nodes":[],"isActive":false},{"title":"Global health and health security","url":"/en-gb/responsibility/global-health-and-health-security/","nodes":[{"title":"Global health","url":"/en-gb/responsibility/global-health-and-health-security/global-health/","nodes":[],"isActive":false},{"title":"Health security","url":"/en-gb/responsibility/global-health-and-health-security/health-security/","nodes":[],"isActive":false},{"title":"Using our science for global health","url":"/en-gb/responsibility/global-health-and-health-security/using-our-science-for-global-health/","nodes":[],"isActive":false},{"title":"Improving access to healthcare","url":"/en-gb/responsibility/global-health-and-health-security/improving-access-to-healthcare/","nodes":[],"isActive":false},{"title":"Africa Open Lab","url":"/en-gb/responsibility/global-health-and-health-security/africa-open-lab/","nodes":[],"isActive":false}],"isActive":false},{"title":"Environment","url":"/en-gb/responsibility/environment/","nodes":[{"title":"Climate","url":"/en-gb/responsibility/environment/climate/","nodes":[],"isActive":false},{"title":"Freshwater","url":"/en-gb/responsibility/environment/freshwater/","nodes":[],"isActive":false},{"title":"Land","url":"/en-gb/responsibility/environment/land/","nodes":[],"isActive":false},{"title":"Oceans","url":"/en-gb/responsibility/environment/oceans/","nodes":[],"isActive":false},{"title":"Materials and waste","url":"/en-gb/responsibility/environment/materials-and-waste/","nodes":[],"isActive":false},{"title":"Health system sustainability","url":"/en-gb/responsibility/environment/health-system-sustainability/","nodes":[],"isActive":false}],"isActive":false},{"title":"Inclusion","url":"/en-gb/responsibility/inclusion/","nodes":[],"isActive":false},{"title":"Ethical standards","url":"/en-gb/responsibility/ethical-standards/","nodes":[{"title":"Working with third parties","url":"/en-gb/responsibility/ethical-standards/working-with-third-parties/","nodes":[],"isActive":false},{"title":"Public policy and patient advocacy","url":"/en-gb/responsibility/ethical-standards/public-policy-and-patient-advocacy/","nodes":[],"isActive":false},{"title":"Human rights","url":"/en-gb/responsibility/ethical-standards/human-rights/","nodes":[],"isActive":false},{"title":"Use of animals","url":"/en-gb/responsibility/ethical-standards/use-of-animals/","nodes":[],"isActive":false},{"title":"Engaging with healthcare professionals","url":"/en-gb/responsibility/ethical-standards/engaging-with-healthcare-professionals/","nodes":[],"isActive":false}],"isActive":false},{"title":"Product governance","url":"/en-gb/responsibility/product-governance/","nodes":[],"isActive":false},{"title":"Grants and donations","url":"/en-gb/responsibility/grants-and-donations/","nodes":[],"isActive":false},{"title":"Charitable investments ","url":"/en-gb/responsibility/charitable-investments/","nodes":[],"isActive":false},{"title":"Responsibility reports","url":"/en-gb/responsibility/responsibility-reports/","nodes":[{"title":"Reports archive","url":"/en-gb/responsibility/responsibility-reports/responsibility-reports-archive/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"Inclusion","image":{"src":"/media/2u2dowa1/web16-header-stvg_2_2022_port_13_hess_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebc1b88030","alt":"Lab technician smiling","darkModeSrc":"/media/2u2dowa1/web16-header-stvg_2_2022_port_13_hess_nav.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebc1b88030"},"link":{"text":"FEATURED SECTION","href":"/en-gb/responsibility/inclusion/","openInNewWindowText":null}},{"text":"Our policy positions","image":{"src":"/media/110ltmz5/gsk_texture_fluid_03_a_cmyk_web-size_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebbe9b61b0","alt":"GSK orange texture","darkModeSrc":"/media/110ltmz5/gsk_texture_fluid_03_a_cmyk_web-size_nav.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebbe9b61b0"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/company/policy-positions/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Investors","url":"/en-gb/investors/","nodes":[{"title":"Why invest in GSK?","url":"/en-gb/investors/why-invest-in-gsk/","nodes":[],"isActive":false},{"title":"Quarterly results","url":"/en-gb/investors/quarterly-results/","nodes":[],"isActive":false},{"title":"Financial reports","url":"/en-gb/investors/financial-reports/","nodes":[{"title":"Annual Report 2025","url":"/en-gb/investors/financial-reports/annual-report-2025/","nodes":[],"isActive":false},{"title":"Corporate reports archive","url":"/en-gb/investors/financial-reports/corporate-reports-archive/","nodes":[],"isActive":false}],"isActive":false},{"title":"Responsible business","url":"/en-gb/investors/responsible-business/","nodes":[],"isActive":false},{"title":"Speeches and presentations","url":"/en-gb/investors/speeches-and-presentations/","nodes":[],"isActive":true},{"title":"Science publications","url":"/en-gb/investors/science-publications/","nodes":[],"isActive":false},{"title":"Events calendar","url":"/en-gb/investors/events-calendar/","nodes":[],"isActive":false},{"title":"Dividend and share price","url":"/en-gb/investors/dividend-and-share-price/","nodes":[{"title":"GSK share price","url":"/en-gb/investors/dividend-and-share-price/gsk-share-price/","nodes":[],"isActive":false},{"title":"Share price calculators (GBp/USD)","url":"/en-gb/investors/dividend-and-share-price/share-price-calculators-gbpusd/","nodes":[],"isActive":false},{"title":"Dividend calculators (GBp/USD)","url":"/en-gb/investors/dividend-and-share-price/dividend-calculators-gbpusd/","nodes":[],"isActive":false},{"title":"Dividend calendar","url":"/en-gb/investors/dividend-and-share-price/dividend-calendar/","nodes":[],"isActive":false}],"isActive":false},{"title":"Analyst consensus","url":"/en-gb/investors/analyst-consensus/","nodes":[],"isActive":false},{"title":"Stock exchange announcements","url":"/en-gb/investors/stock-exchange-announcements/","nodes":[{"title":"London (RNS)","url":"/en-gb/investors/stock-exchange-announcements/london-rns/","nodes":[],"isActive":false},{"title":"London (RNS) inside information","url":"/en-gb/investors/stock-exchange-announcements/london-rns-inside-information/","nodes":[],"isActive":false},{"title":"New York (SEC)","url":"/en-gb/investors/stock-exchange-announcements/new-york-sec/","nodes":[],"isActive":false},{"title":"Sign up for announcements","url":"/en-gb/investors/stock-exchange-announcements/sign-up-for-announcements/","nodes":[],"isActive":false}],"isActive":false},{"title":"Shareholder information","url":"/en-gb/investors/shareholder-information/","nodes":[{"title":"Manage your shares","url":"/en-gb/investors/shareholder-information/manage-your-shares/","nodes":[],"isActive":false},{"title":"Annual General Meeting","url":"/en-gb/investors/shareholder-information/annual-general-meeting/","nodes":[],"isActive":false},{"title":"General Meeting","url":"/en-gb/investors/shareholder-information/general-meeting/","nodes":[],"isActive":false},{"title":"Annual Governance Meeting","url":"/en-gb/investors/shareholder-information/annual-governance-meeting/","nodes":[],"isActive":false},{"title":"Corporate sponsored nominee service","url":"/en-gb/investors/shareholder-information/corporate-sponsored-nominee-service/","nodes":[],"isActive":false},{"title":"Our ADR programme","url":"/en-gb/investors/shareholder-information/adr-programme/","nodes":[],"isActive":false},{"title":"Asset reunification - Georgeson ","url":"/en-gb/investors/shareholder-information/asset-reunification-georgeson/","nodes":[],"isActive":false},{"title":"Share scam alert","url":"/en-gb/investors/shareholder-information/share-scam-alert/","nodes":[],"isActive":false},{"title":"Privacy notice for ordinary shareholders","url":"/en-gb/investors/shareholder-information/privacy-notice-for-ordinary-shareholders/","nodes":[],"isActive":false},{"title":"FAQs","url":"/en-gb/investors/shareholder-information/shareholder-faqs/","nodes":[],"isActive":false}],"isActive":false},{"title":"Corporate actions","url":"/en-gb/investors/corporate-actions/","nodes":[{"title":"Consumer Healthcare Demerger","url":"/en-gb/investors/corporate-actions/consumer-healthcare-demerger/","nodes":[],"isActive":false},{"title":"Consumer Healthcare Joint Venture","url":"/en-gb/investors/corporate-actions/consumer-healthcare-joint-venture/","nodes":[],"isActive":false},{"title":"Agreement to acquire TESARO","url":"/en-gb/investors/corporate-actions/agreement-to-acquire-tesaro/","nodes":[],"isActive":false}],"isActive":false},{"title":"Debt investors","url":"/en-gb/investors/debt-investors/","nodes":[],"isActive":false},{"title":"Investor contacts","url":"/en-gb/investors/investor-contacts/","nodes":[],"isActive":false}],"isActive":true,"promos":[{"text":"Press releases","image":{"src":"/media/hb1dfygw/ware_3_2022_prodassmb_28_hess_nav.jpeg?width=329&height=185&format=webp&quality=100&v=1dba2ebc6f12bb0","alt":"Lab machinery","darkModeSrc":"/media/hb1dfygw/ware_3_2022_prodassmb_28_hess_nav.jpeg?width=329&height=185&format=webp&quality=50&v=1dba2ebc6f12bb0"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/media/press-releases/","openInNewWindowText":null}},{"text":"Our pipeline","image":{"src":"/media/2kyan0vw/ware_3_2022_prodqc_14_hess.jpeg?width=329&height=185&format=webp&quality=100&v=1dba2ebc701f490","alt":"Case of vials","darkModeSrc":"/media/2kyan0vw/ware_3_2022_prodqc_14_hess.jpeg?width=329&height=185&format=webp&quality=50&v=1dba2ebc701f490"},"link":{"text":"SPOTLIGHT ON","href":"/en-gb/innovation/pipeline/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Media","url":"/en-gb/media/","nodes":[{"title":"Press releases","url":"/en-gb/media/press-releases/","nodes":[],"isActive":false},{"title":"Media contacts","url":"/en-gb/media/media-contacts/","nodes":[],"isActive":false},{"title":"Media library","url":"/en-gb/media/media-library/","nodes":[],"isActive":false},{"title":"Zantac litigation","url":"/en-gb/media/zantac-litigation/","nodes":[],"isActive":false},{"title":"GSK's position on Flovent","url":"/en-gb/media/gsks-position-on-flovent/","nodes":[],"isActive":false},{"title":"Our social media","url":"/en-gb/media/social-media/","nodes":[],"isActive":false},{"title":"Podcasts","url":"/en-gb/media/podcasts/","nodes":[],"isActive":false},{"title":"RSS feeds","url":"/en-gb/media/rss-feeds/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Behind the science magazine","image":{"src":"/media/ukvllwft/vaccine-manufacturing-production-line-2.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebb585f130","alt":"Scientist works in a futurist vaccine laboratory for GSK","darkModeSrc":"/media/ukvllwft/vaccine-manufacturing-production-line-2.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebb585f130"},"link":{"text":"Spotlight on","href":"/en-gb/behind-the-science-magazine/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"Careers","url":"/en-gb/careers/","nodes":[{"title":"Search jobs","url":"/en-gb/careers/search-jobs/","nodes":[],"isActive":false},{"title":"Featured careers","url":"/en-gb/careers/featured-careers/","nodes":[{"title":"A career in data","url":"/en-gb/careers/featured-careers/a-career-in-data/","nodes":[],"isActive":false}],"isActive":false},{"title":"Life at GSK","url":"/en-gb/careers/life-at-gsk/","nodes":[],"isActive":false},{"title":"Experienced professionals","url":"/en-gb/careers/experienced-professionals/","nodes":[{"title":"Business operations","url":"/en-gb/careers/experienced-professionals/business-operations/","nodes":[],"isActive":false},{"title":"Engineering at GSK ","url":"/en-gb/careers/experienced-professionals/engineering/","nodes":[],"isActive":false},{"title":"Global supply chain","url":"/en-gb/careers/experienced-professionals/global-supply-chain/","nodes":[],"isActive":false},{"title":"Sales and marketing","url":"/en-gb/careers/experienced-professionals/sales-and-marketing/","nodes":[],"isActive":false},{"title":"Research and development","url":"/en-gb/careers/experienced-professionals/research-and-development/","nodes":[{"title":"Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS)","url":"/en-gb/careers/experienced-professionals/research-and-development/chemical-manufacturing-and-controls-cmc-medicine-development-and-supply-mds/","nodes":[],"isActive":false},{"title":"Genomic sciences","url":"/en-gb/careers/experienced-professionals/research-and-development/genomic-sciences/","nodes":[],"isActive":false}],"isActive":false},{"title":"Technology","url":"/en-gb/careers/experienced-professionals/technology/","nodes":[],"isActive":false}],"isActive":false},{"title":"Early careers","url":"/en-gb/careers/early-careers/","nodes":[{"title":"Application process","url":"/en-gb/careers/early-careers/application-process/","nodes":[],"isActive":false},{"title":"Apprentice programmes","url":"/en-gb/careers/early-careers/apprentice-programmes/","nodes":[],"isActive":false},{"title":"Internships and placements","url":"/en-gb/careers/early-careers/internships-and-placements/","nodes":[],"isActive":false},{"title":"Graduate programme","url":"/en-gb/careers/early-careers/graduate-programme/","nodes":[{"title":"Business operations","url":"/en-gb/careers/early-careers/graduate-programme/business-operations/","nodes":[],"isActive":false},{"title":"Engineering","url":"/en-gb/careers/early-careers/graduate-programme/engineering/","nodes":[],"isActive":false},{"title":"Manufacturing & supply","url":"/en-gb/careers/early-careers/graduate-programme/manufacturing-supply/","nodes":[],"isActive":false},{"title":"Commercial ","url":"/en-gb/careers/early-careers/graduate-programme/commercial/","nodes":[],"isActive":false},{"title":"Research & development","url":"/en-gb/careers/early-careers/graduate-programme/research-development/","nodes":[],"isActive":false},{"title":"Digital & tech","url":"/en-gb/careers/early-careers/graduate-programme/digital-tech/","nodes":[],"isActive":false},{"title":"Manufacturing sciences & technology","url":"/en-gb/careers/early-careers/graduate-programme/manufacturing-sciences-technology/","nodes":[],"isActive":false}],"isActive":false},{"title":"Post graduate opportunities","url":"/en-gb/careers/early-careers/post-graduate-opportunities/","nodes":[],"isActive":false},{"title":"Frequently asked questions","url":"/en-gb/careers/early-careers/frequently-asked-questions/","nodes":[],"isActive":false}],"isActive":false},{"title":"Veterans","url":"/en-gb/careers/veterans/","nodes":[],"isActive":false},{"title":"Our global and regional hubs","url":"/en-gb/careers/our-global-and-regional-hubs/","nodes":[],"isActive":false},{"title":"How we hire","url":"/en-gb/careers/how-we-hire/","nodes":[{"title":"Fraudulent internet recruitment activities","url":"/en-gb/careers/how-we-hire/fraudulent-internet-recruitment-activities/","nodes":[],"isActive":false},{"title":"Frequently asked questions","url":"/en-gb/careers/how-we-hire/frequently-asked-questions/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"Outstanding people","image":{"src":"/media/kgwp0dc5/sddefault-2.jpg?rxy=0.425,0.51807228915662651&width=329&height=185&format=webp&quality=100&v=1dba2eba773f3d0","alt":"Angeles sitting on a sofa in a pink shirt","darkModeSrc":"/media/kgwp0dc5/sddefault-2.jpg?rxy=0.425,0.51807228915662651&width=329&height=185&format=webp&quality=50&v=1dba2eba773f3d0"},"link":{"text":"Spotlight on","href":"/en-gb/company/outstanding-people/","openInNewWindowText":null}},{"text":"Inclusion","image":{"src":"/media/2u2dowa1/web16-header-stvg_2_2022_port_13_hess_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dba2ebc1b88030","alt":"Lab technician smiling","darkModeSrc":"/media/2u2dowa1/web16-header-stvg_2_2022_port_13_hess_nav.jpg?width=329&height=185&format=webp&quality=50&v=1dba2ebc1b88030"},"link":{"text":"Spotlight on","href":"/en-gb/responsibility/inclusion/","openInNewWindowText":null}}]}],"skipToContent":"Skip to content","skipToSearch":"Skip to search","typeaheadSearch":{"apiEndpoint":"api/search/typeahead?siteContainerId=1703","searchFieldPlaceholderText":"Enter a search term...","searchPage":"/en-gb/search/","ariaLabel":"Submit form"},"ariaLabel":"Global navigation"},"footer":{"logo":null,"copyrightText":"This is our global website, intended for visitors seeking information on GSK's worldwide business. Our market sites can be reached by visiting our location selector.
\n\n
© 2001-2026 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.
\nGSK plc. Registered in England and Wales No. 3888792.
\nRegistered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG
","modernSlaveryStatement":{"name":"Modern Slavery Act Statement 2025","url":"/media/5ladhmeu/modern-slavery-act-statement-2025.pdf","fileExtension":"PDF","fileSize":"187.7KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window"},"sections":{"socialMedia":{"columnTitle":"Follow us on:","socialMediaItems":[{"globalLink":{"text":null,"href":"http://www.linkedin.com/company/glaxosmithkline","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK on Linkedin","customIcon":null,"showPopupMenu":false,"type":"LinkedIn"},{"globalLink":{"text":null,"href":"http://twitter.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK X page","customIcon":null,"showPopupMenu":false,"type":"X"},{"globalLink":{"text":null,"href":"https://bsky.app/profile/gsk.bsky.social/","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"","customIcon":null,"showPopupMenu":false,"type":"Bluesky"},{"globalLink":{"text":null,"href":"https://www.instagram.com/gsk/","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK Instagram","customIcon":null,"showPopupMenu":false,"type":"Instagram"},{"globalLink":{"text":null,"href":"https://www.facebook.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK Facebook page","customIcon":null,"showPopupMenu":false,"type":"Facebook"},{"globalLink":{"text":null,"href":"http://www.youtube.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Visit GSK YouTube Channel","customIcon":null,"showPopupMenu":false,"type":"Youtube"},{"globalLink":{"text":null,"href":"/en-gb/media/rss-feeds/","openInNewWindowText":null},"localLink":null,"ariaLabel":"Visit GSK RSS feeds","customIcon":null,"showPopupMenu":false,"type":"Rss"}]},"columns":[{"columnTitle":"GSK websites","links":[{"text":"Locations selector","href":"/en-gb/locations/","openInNewWindowText":null},{"text":"Social media directory","href":"/en-gb/media/social-media/","openInNewWindowText":null},{"text":"GSKPro for healthcare professionals","href":"https://www.gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"GSK study register","href":"https://www.gsk-studyregister.com/en/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Supplier website","href":"https://supplier.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"ViiV Healthcare","href":"https://viivhealthcare.com/","target":"_blank","openInNewWindowText":"Opens in a new window"}]},{"columnTitle":"Quick links","links":[{"text":"Behind the Science magazine","href":"/en-gb/behind-the-science-magazine/","openInNewWindowText":null},{"text":"Company","href":"/en-gb/company/","openInNewWindowText":null},{"text":"Innovation","href":"/en-gb/innovation/","openInNewWindowText":null},{"text":"Products","href":"/en-gb/products/","openInNewWindowText":null},{"text":"Responsibility","href":"/en-gb/responsibility/","openInNewWindowText":null},{"text":"Investors","href":"/en-gb/investors/","openInNewWindowText":null},{"text":"Media","href":"/en-gb/media/","openInNewWindowText":null},{"text":"Careers","href":"/en-gb/careers/","openInNewWindowText":null}]},{"columnTitle":"Get in touch","links":[{"text":"Contact us","href":"/en-gb/contact-us/","openInNewWindowText":null},{"text":"Partnerships","href":"/en-gb/innovation/partnerships/","openInNewWindowText":null},{"text":"Report a possible side effect","href":"/en-gb/contact-us/report-a-possible-side-effect/","openInNewWindowText":null},{"text":"GSK Speak up","href":"https://www.gsk.com/speakup","target":"_blank","openInNewWindowText":"Opens in a new window"}]}]},"bottomLinks":[{"text":"Accessibility","href":"/en-gb/accessibility/","openInNewWindowText":null},{"text":"Digital sustainability","href":"/en-gb/digital-sustainability/","openInNewWindowText":null},{"text":"Terms of use","href":"/en-gb/terms-of-use/","openInNewWindowText":null},{"text":"Cookie policy","href":"/en-gb/cookie-policy/","openInNewWindowText":null},{"text":"Privacy notice","href":"https://privacy.gsk.com/en-gb/privacy-notice/general","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Sitemap","href":"/en-gb/sitemap/","openInNewWindowText":null}],"continueToLink":{"text":"Science publications","href":"/en-gb/investors/science-publications/","openInNewWindowText":null,"continueTo":""},"legalApprovalText":""},"sharing":{"description":"Search through our archive of speeches and presentations from conferences and events","og":[{"property":"og:title","content":"Speeches and presentations"},{"property":"og:description","content":"Search through our archive of speeches and presentations from conferences and events"},{"property":"og:image","content":"https://www.gsk.com/media/zp5fkarg/gsk_03_2022_port_4_eagle_orange.jpg?rxy=0.53166666666666662,0.375&width=600&format=webp&quality=100&v=1dba2ec082c63b0"},{"property":"og:url","content":"https://www.gsk.com/en-gb/investors/speeches-and-presentations/"}],"twitter":[{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:site","content":"@gsk"},{"name":"twitter:title","content":"Speeches and presentations"},{"name":"twitter:description","content":"Search through our archive of speeches and presentations from conferences and events"},{"name":"twitter:image","content":"https://www.gsk.com/media/zp5fkarg/gsk_03_2022_port_4_eagle_orange.jpg?rxy=0.53166666666666662,0.375&width=600&format=webp&quality=100&v=1dba2ec082c63b0"},{"name":"twitter:url","content":"https://www.gsk.com/en-gb/investors/speeches-and-presentations"}]},"stickyShare":null,"exitSitePreferences":{"popupEnabled":false,"title":"","texts":"","continueText":"Continue","cancelText":"Cancel","exclusionUrls":[]},"settings":{"optionalStylesheetLink":null,"themeColorHexCode":null,"headerLogoLightTheme":null,"headerLogoDarkTheme":null,"footerLogo":{"src":"https://www.gsk.com/media/0jwou3xu/gsk-logo.png?width=104&format=webp&quality=100&v=1dbf4b05a4e6470","alt":"Gsk Logo","darkModeSrc":"https://www.gsk.com/media/0jwou3xu/gsk-logo.png?width=104&format=webp&quality=50&v=1dbf4b05a4e6470"},"scripts":[{"pageLocation":"Top","text":" \n"}],"globalWebsiteLink":null,"googleMapsApiKey":"AIzaSyA2QMg4Ww6djPKb7b9BraQn4kgJmDaLblg","textToSpeechApiKey":"70ab0a79-1d92-4286-86d2-abdd71cc785c","bingVerificationCode":"","googleAnalytics":"","siteTitle":" | GSK"},"pageSettings":{"disableBackToTopButton":false,"backToTopButtonText":"Back to top","robotsNoFollow":false,"robotsNoIndex":false,"canonicalUrl":"https://www.gsk.com/en-gb/investors/speeches-and-presentations/"},"tealiumSettings":{"enabled":false,"data":""},"entryPopup":null,"protectedPage":false,"schema":{"jsonLdSchemas":["{\"@context\":\"https://schema.org\",\"@type\":\"CollectionPage\",\"name\":\"Speeches and presentations\",\"description\":\"Search through our archive of speeches and presentations from conferences and events\",\"url\":\"https://www.gsk.com/en-gb/investors/speeches-and-presentations/?CacheTarget=NULL\",\"mainEntity\":{\"@type\":\"ItemList\",\"itemListElement\":[{\"@type\":\"Event\",\"name\":\"Citi European Healthcare CEO Conference\",\"description\":\"Luke Miels, Chief Executive Officer, will attend the Citi European Healthcare CEO Conference in London on Wednesday, 10 June 2026.\",\"image\":\"https://www.gsk.com/media/xqdbtzpm/luke-miels.jpg\",\"startDate\":\"2026-06-10\"},{\"@type\":\"Event\",\"name\":\"BNP Paribas Exane CEO Conference\",\"description\":\"Julie Brown, Chief Financial Officer, will attend the BNP Paribas Exane CEO Conference in Paris on Wednesday, 3 June 2026.\",\"image\":\"https://www.gsk.com/media/fj4mgijo/glt-imagery-julie-brown-chief-financial-officer11.jpg\",\"startDate\":\"2026-06-03\"},{\"@type\":\"Event\",\"name\":\"Jefferies Global Healthcare Conference\",\"description\":\"Hesham Abdullah, SVP, Global Oncology R\\u0026amp;D, will participate at the Jefferies Global Healthcare Conference in New York on Wednesday, 3 June 2026.\",\"image\":\"https://www.gsk.com/media/fjffwi2b/ci8a9976.jpg\",\"startDate\":\"2026-06-03\"},{\"@type\":\"Event\",\"name\":\"Barclays European Leadership Conference\",\"description\":\"David Redfern, President Corporate Development, will attend the Barclays European Leadership Conference, taking place in London on Thursday, 21 May 2026.\",\"image\":\"https://www.gsk.com/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg\",\"startDate\":\"2026-05-21\"},{\"@type\":\"Event\",\"name\":\"Rothschild \\u0026 Co Global Equities Conference\",\"description\":\"David Redfern, President Corporate Development, will attend the Rothschild \\u0026amp; Co\\u0027s upcoming Global Equities Conference in Toronto on Tuesday, 12 May 2026.\",\"image\":\"https://www.gsk.com/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg\",\"startDate\":\"2026-05-12\"},{\"@type\":\"Event\",\"name\":\"Goldman Sachs 9th Annual Biopharma Innovation Summit\",\"description\":\"Kaivan Khavandi, SVP, R\\u0026amp;D Head, Respiratory, Immunology \\u0026amp; Inflammation, participated in a fireside chat at the Goldman Sachs 9th Annual Biopharma Innovation Summit in London on Thursday, 26 March 2026 at 09:00 am GMT.\\nNo replay is available.\",\"image\":\"https://www.gsk.com/media/fukp3c1q/kaivan-profile-image.jpg\",\"startDate\":\"2026-03-26\"},{\"@type\":\"Event\",\"name\":\"BNP Paribas Healthcare Conference\",\"description\":\"Julie Brown, Chief Financial Officer, attended the BNP Paribas Healthcare Conference in London on Tuesday, 24 March 2026.\",\"image\":\"https://www.gsk.com/media/foedxdzw/julie-b.jpg\",\"startDate\":\"2026-03-24\"},{\"@type\":\"Event\",\"name\":\"Barclays 28th Annual Global Healthcare Conference\",\"description\":\"David Redfern, President Corporate Development, participated in a fireside chat at the Barclays 28th Annual Global Healthcare Conference in Miami, FL on Wednesday, 11 March 2026 at 11:30 am EST/4:30 pm GMT.\",\"image\":\"https://www.gsk.com/media/vk5kqg4c/gskh_04_2022_port_david_02_hess.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Listen to the webcast\",\"url\":\"https://event.webcasts.com/starthere.jsp?ei=1755067\\u0026tp_key=42d2e7c975\\u0026tp_special=8\"},\"startDate\":\"2026-03-11\"},{\"@type\":\"Event\",\"name\":\"Leerink Partners Global Healthcare Conference\",\"description\":\"David Redfern, President Corporate Development, attended the Leerink Partners Global Healthcare Conference in Miami, FL on Tuesday, 10 March 2026.\",\"image\":\"https://www.gsk.com/media/vk5kqg4c/gskh_04_2022_port_david_02_hess.jpg\",\"startDate\":\"2026-03-10\"},{\"@type\":\"Event\",\"name\":\"UBS European Healthcare Conference\",\"description\":\"David Redfern, President Corporate Development, attended the UBS European Healthcare Conference in London on Wednesday, 4 March 2026.\",\"image\":\"https://www.gsk.com/media/vk5kqg4c/gskh_04_2022_port_david_02_hess.jpg\",\"startDate\":\"2026-03-04\"},{\"@type\":\"Event\",\"name\":\"GSK enters agreement to acquire 35Pharma Inc.\",\"description\":\"Sell-side analysts calls with Nina Mojas, President, Global Product Strategy and Kaivan Khavandi, SVP, R\\u0026amp;D Head, Respiratory, Immunology \\u0026amp; Inflammation.\",\"image\":\"https://www.gsk.com/media/vrbdwajb/gsk-and-35pharma-logo.jpg\",\"startDate\":\"2026-02-25\",\"workFeatured\":{\"@type\":\"DataDownload\",\"name\":\"Download the presentation\",\"contentUrl\":\"https://www.gsk.com/media/mrwpanl2/agreement-to-acquire-35pharma-inc.pdf\",\"encodingFormat\":\"application/pdf\"}},{\"@type\":\"Event\",\"name\":\"GSK enters agreement to acquire RAPT Therapeutics\",\"description\":\"Sell-side analysts calls with Luke Miels, Chief Executive Officer, Tony Wood, Chief Scientific Officer and Nina Mojas, President, Global Product Strategy.\",\"image\":\"https://www.gsk.com/media/jzvdn1cl/gsk-and-rapt-logo.jpg\",\"startDate\":\"2026-01-20\",\"workFeatured\":{\"@type\":\"DataDownload\",\"name\":\"Download the presentation\",\"contentUrl\":\"https://www.gsk.com/media/paddln2v/agreement-to-acquire-rapt-therapeutics-slides.pdf\",\"encodingFormat\":\"application/pdf\"}},{\"@type\":\"Event\",\"name\":\"J.P. Morgan 2026 Healthcare Conference, San Francisco\",\"description\":\"Tony Wood, Chief Scientific Officer, participated in a fireside chat during the J.P. Morgan 2026 Healthcare Conference in San Francisco on Tuesday, 13 January 2026.\",\"image\":\"https://www.gsk.com/media/45khexa4/tony-16x9.jpg\",\"startDate\":\"2026-01-13\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"See recent quarterly results slides Q3 2025\",\"contentUrl\":\"https://www.gsk.com/media/0qfjbtd3/q3-2025-results-slides.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"See recent quarterly results slides Q2 2025\",\"contentUrl\":\"https://www.gsk.com/media/fonb14xu/q2-2025-results-slides.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"Citi 2025 Global Healthcare Conference, Miami\",\"description\":\"Deborah Waterhouse, Chief Executive Officer of ViiV Healthcare, and Dr. Kimberly Smith, Head of R\\u0026amp;D at ViiV Healthcare, participated at the Citi 2025 Global Healthcare Conference in Miami on Thursday, 4 December 2025.\",\"image\":\"https://www.gsk.com/media/t00bmup1/kim-and-deborah.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Listen to the webcast\",\"url\":\"https://kvgo.com/global-healthcare-conference-2025/gsk-plc-december-2025\"},\"startDate\":\"2025-12-04\"},{\"@type\":\"Event\",\"name\":\"Evercore 8th Annual Evercore Healthcare Conference, Miami\",\"description\":\"Deborah Waterhouse, Chief Executive Officer of ViiV Healthcare, and Dr. Kimberly Smith, Head of R\\u0026amp;D at ViiV Healthcare, participated at the Evercore 8th Annual Evercore Healthcare Conference in Miami on Wednesday, 3 December 2025.\",\"image\":\"https://www.gsk.com/media/sedfczop/deborah-and-kim.jpg\",\"startDate\":\"2025-12-03\"},{\"@type\":\"Event\",\"name\":\"Jefferies London Healthcare Conference, London\",\"description\":\"Tony Wood, Chief Scientific Officer, attended the Jefferies Healthcare Conference in London on Tuesday, 18 and Wednesday, 19 November 2025.\",\"image\":\"https://www.gsk.com/media/ztmb1w5s/stvg_04_2022_port_tony_05_hess_27200.jpg\",\"startDate\":\"2025-11-18\"},{\"@type\":\"Event\",\"name\":\"J.P. Morgan UK Leaders Conference, London\",\"description\":\"Julie Brown, Chief Financial Officer, attended the J.P. Morgan UK Leaders Conference in London on Tuesday, 18 November 2025.\",\"image\":\"https://www.gsk.com/media/fj4mgijo/glt-imagery-julie-brown-chief-financial-officer11.jpg\",\"startDate\":\"2025-11-18\"},{\"@type\":\"Event\",\"name\":\"UBS European Conference, London\",\"description\":\"David Redfern, President Corporate Development, attended the UBS European Conference in London on Wednesday, 12 November 2025.\",\"image\":\"https://www.gsk.com/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg\",\"startDate\":\"2025-11-12\"},{\"@type\":\"Event\",\"name\":\"BofA 2025 Global Healthcare Conference, London\",\"description\":\"Julie Brown, Chief Financial Officer and Tony Wood, Chief Scientific Officer, participated in a fireside chat at the BofA Global Healthcare Conference in London on Wednesday, 24 September 2025.\",\"image\":\"https://www.gsk.com/media/pvibrwwc/julie-brown-tony-wood-16x9.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Listen to the webcast\",\"url\":\"https://bofa.veracast.com/webcasts/bofa/globalhealthcareuk2025/Y4G9dM.cfm\"},\"startDate\":\"2025-09-24\"},{\"@type\":\"Event\",\"name\":\"Morgan Stanley 23rd Annual Global Healthcare Conference, New York\",\"description\":\"Hesham Abdullah, SVP, Global Oncology R\\u0026amp;D, participated at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York on Tuesday, 9 September 2025.\",\"image\":\"https://www.gsk.com/media/uiwnz3xl/hesham-photo-navy-blue-10may23-teams-outlook-workday-683x1024.jpg\",\"startDate\":\"2025-09-09\"},{\"@type\":\"Event\",\"name\":\"Citi European Healthcare Conference, London\",\"description\":\"Tony Wood, Chief Scientific Officer, attended the Citi European Healthcare Conference in London on Tuesday, 17 June 2025.\",\"image\":\"https://www.gsk.com/media/45khexa4/tony-16x9.jpg\",\"startDate\":\"2025-06-17\"},{\"@type\":\"Event\",\"name\":\"Goldman Sachs Global Healthcare Conference, Miami\",\"description\":\"Kimberly Smith, Head of R\\u0026amp;D at ViiV Healthcare, attended the Goldman Sachs Global Healthcare Conference in Miami on Monday, 9 June 2025.\",\"image\":\"https://www.gsk.com/media/nnwpsa0f/dr-kimberly_smith092.jpg\",\"startDate\":\"2025-06-09\"},{\"@type\":\"Event\",\"name\":\"NYSE Health Care Virtual Investor Access Day\",\"description\":\"David Redfern, President Corporate Development, attended the NYSE Health Care Virtual Investor Access Day on Thursday, 5 June 2025.\",\"image\":\"https://www.gsk.com/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg\",\"startDate\":\"2025-06-05\"},{\"@type\":\"Event\",\"name\":\"BNP Paribas Exane CEO Conference, Paris\",\"description\":\"Julie Brown, Chief Financial Officer, attended the BNP Paribas Exane CEO Conference in Paris on Thursday, 5 June 2025.\",\"image\":\"https://www.gsk.com/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg\",\"startDate\":\"2025-06-05\"},{\"@type\":\"Event\",\"name\":\"Goldman Sachs Biopharma Innovation Summit\",\"description\":\"David Redfern, President, Corporate Development, attended the Goldman Sachs Biopharma Innovation Summit in London on Thursday, 27 March 2025.\",\"image\":\"https://www.gsk.com/media/gkynilxm/gskh_04_2022_port_david_02_hess-3.jpg\",\"startDate\":\"2025-03-27\"},{\"@type\":\"Event\",\"name\":\"BNP Paribas Exane Healthcare Conference\",\"description\":\"Julie Brown, Chief Financial Officer, participated in a virtual fireside chat at the BNP Paribas Exane Healthcare Conference on Tuesday, 25 March 2025. \",\"image\":\"https://www.gsk.com/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg\",\"startDate\":\"2025-03-25\"},{\"@type\":\"Event\",\"name\":\"TD Cowen 45th Annual Health Care Conference\",\"description\":\"Luke Miels, Chief Commercial Officer, participated in a fireside chat at the TD Cowen 45th Annual Health Care Conference in Boston on Monday, 3 March 2025.\",\"image\":\"https://www.gsk.com/media/dsghk01j/gskh_05_2022_port_luke_03_sinden_thumb.jpg\",\"startDate\":\"2025-03-03\"},{\"@type\":\"Event\",\"name\":\"43rd Annual J.P. Morgan Healthcare Conference\",\"description\":\"Emma Walmsley, Chief Executive Officer, presented at the 43rd annual JP Morgan Healthcare Conference on Tuesday 14 January. The 40 minute session included a presentation and a moderated Q\\u0026amp;A discussion.\",\"image\":\"https://www.gsk.com/media/bl0nwhzx/gskh_05_2022_port_emma_03_hess.jpg\",\"startDate\":\"2025-01-14\",\"workFeatured\":{\"@type\":\"DataDownload\",\"name\":\"JP Morgan Healthcare Conference presentation\",\"contentUrl\":\"https://www.gsk.com/media/oxpbkchk/gsk-2025-jpm-conf-presentation-14-january-2025.pdf\",\"encodingFormat\":\"application/pdf\"}},{\"@type\":\"Event\",\"name\":\"Meet the management: Early pipeline\",\"description\":\"On 17 December, GSK management held a virtual event, \\u0022Early pipeline\\u0022, featuring a presentation and an interactive Q\\u0026amp;A session.\",\"image\":\"https://www.gsk.com/media/nfnb0ocv/dna-and-tech-image.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the recording\",\"url\":\"https://www.youtube.com/watch?v=_SQKS9TgcxU\"},\"startDate\":\"2024-12-17\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Meet the management: Early pipeline presentation\",\"contentUrl\":\"https://www.gsk.com/media/msnj0zn0/meet-the-management-early-pipeline-presentation.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Meet the management: Early pipeline transcript\",\"contentUrl\":\"https://www.gsk.com/media/snpft0zy/meet-the-management-early-pipeline-transcript.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"Getting Ahead of Multiple Myeloma: Update from ASH\",\"description\":\"GSK held a virtual event \\u0022Getting Ahead of Multiple Myeloma: Update from ASH\\u0022 on 10 December, providing a recap on data presented at the 66th ASH (American Society of Hematology) Annual Meeting. \",\"image\":\"https://www.gsk.com/media/dpwhy5qp/multiple-myeloma-science-image.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the recording\",\"url\":\"https://gsk.zoom.us/webinar/register/WN_E2SWPJKpS5K0d9qM0W455Q\"},\"startDate\":\"2024-12-10\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Getting Ahead of Multiple Myeloma presentation\",\"contentUrl\":\"https://www.gsk.com/media/gfjivioc/gsk-ash-analyst-call-presentation_final.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Getting Ahead of Multiple Myeloma transcript\",\"contentUrl\":\"https://www.gsk.com/media/ifolzuz1/gsk-ash_analyst-call-transcript_final.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"Citi\\u0027s 2024 Global Healthcare Conference\",\"description\":\"Hesham Abdullah, SVP Global Head Oncology, attended Citi\\u0027s 2024 Global Healthcare Conference in Miami on Thursday, 5 December 2024. \",\"image\":\"https://www.gsk.com/media/uiwnz3xl/hesham-photo-navy-blue-10may23-teams-outlook-workday-683x1024.jpg\",\"startDate\":\"2024-12-05\"},{\"@type\":\"Event\",\"name\":\"The 2024 Redburn Atlantic CEO Conference\",\"description\":\"Emma Walmsley, Chief Executive Officer, participated in a virtual fireside chat at the 2024 Redburn Atlantic CEO Conference on Wednesday, 4 December 2024.\",\"image\":\"https://www.gsk.com/media/srkhy1nz/gskh_05_2022_port_emma_03_hess_thumb.jpg\",\"startDate\":\"2024-12-04\"},{\"@type\":\"Event\",\"name\":\"7th Annual Evercore ISI HealthCONx Conference\",\"description\":\"Phil Dormitzer, SVP, Head of Vaccines R\\u0026amp;D, attended the 7th Annual Evercore ISI HealthCONx Conference in Miami on Wednesday, 4 December 2024. \",\"image\":\"https://www.gsk.com/media/bu0bd4we/phil-dormitzer.jpg\",\"startDate\":\"2024-12-04\"},{\"@type\":\"Event\",\"name\":\"Bernstein Premium Review Conference\",\"description\":\"David Redfern, President Corporate Development, attended the Bernstein Premium Review Conference in Paris on Wednesday, 27 November 2024.\",\"image\":\"https://www.gsk.com/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg\",\"startDate\":\"2024-11-27\"},{\"@type\":\"Event\",\"name\":\"Jefferies London Healthcare Conference \",\"description\":\"Tony Wood, Chief Scientific Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, 19 November 2024 in London.\",\"image\":\"https://www.gsk.com/media/45khexa4/tony-16x9.jpg\",\"startDate\":\"2024-11-19\"},{\"@type\":\"Event\",\"name\":\"JP Morgan UK Leaders Conference\",\"description\":\"Julie Brown, Chief Financial Officer, participated in a fireside chat at the JP Morgan UK Leaders Conference on Tuesday, 19 November 2024 in London. \",\"image\":\"https://www.gsk.com/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg\",\"startDate\":\"2024-11-19\"},{\"@type\":\"Event\",\"name\":\"Guggenheim\\u0027s Inaugural Healthcare Innovation Conference\",\"description\":\"Emma Walmsley, Chief Executive Officer, participated in a fireside chat at Guggenheim\\u0027s Inaugural Healthcare Innovation Conference on Tuesday, 12 November 2024 in Boston.\",\"image\":\"https://www.gsk.com/media/bl0nwhzx/gskh_05_2022_port_emma_03_hess.jpg\",\"startDate\":\"2024-11-12\"},{\"@type\":\"Event\",\"name\":\"Bernstein 21st Pan European Annual Strategic Decisions Conference\",\"description\":\"David Redfern, President, Corporate Development, attended the Bernstein 21st Pan European Annual Strategic Decisions Conference in London on Wednesday, 25 September 2024.\",\"image\":\"https://www.gsk.com/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg\",\"startDate\":\"2024-09-25\"},{\"@type\":\"Event\",\"name\":\"BofA 2024 Global Healthcare Conference, London\",\"description\":\"Julie Brown, Chief Financial Officer, participated in a fireside chat at the BofA Global Healthcare Conference on Thursday, 19 September 2024 in London at 09:05 BST.\",\"image\":\"https://www.gsk.com/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg\",\"startDate\":\"2024-09-19\"},{\"@type\":\"Event\",\"name\":\"Morgan Stanley 22nd Annual Global Healthcare Conference, NYC\",\"description\":\"David Redfern, President, Corporate Development, participated in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference taking place in New York on Thursday, 5 September 2024 at 4:05am EST.\",\"image\":\"https://www.gsk.com/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg\",\"startDate\":\"2024-09-05\"},{\"@type\":\"Event\",\"name\":\"Getting ahead of Oncology with GSK management\",\"description\":\"GSK management held a virtual event on 17 June at 8:00 AM EDT / 1:00 PM BST. The event, \\u0022Getting Ahead of Oncology,\\u0022 featured a presentation and an interactive Q\\u0026amp;A session. A replay is available on demand.\",\"image\":\"https://www.gsk.com/media/hmljdzsk/endometrial-cancer-science-image-rgb.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the recording\",\"url\":\"https://youtu.be/rIBaUlr4XqA\"},\"startDate\":\"2024-06-17\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Getting ahead of Oncology presentation\",\"contentUrl\":\"https://www.gsk.com/media/jhgjf5m3/getting-ahead-of-oncology-presentation.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Getting ahead of Oncology transcript\",\"contentUrl\":\"https://www.gsk.com/media/fbhni5vm/getting-ahead-of-oncology-transcript.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"BNP Paribas Exane CEO Conference\",\"description\":\"Julie Brown, Chief Financial Officer, participated in a fireside chat at the BNP Paribas Exane CEO Conference in Paris on Thursday, 6 June 2024.\",\"image\":\"https://www.gsk.com/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg\",\"startDate\":\"2024-06-06\"},{\"@type\":\"Event\",\"name\":\"J.P. Morgan EMEA All Stars Forum\",\"description\":\"David Redfern, President, Corporate Development, attended the J.P. Morgan EMEA All Stars Forum in Boston on Wednesday, 22 May 2024.\",\"image\":\"https://www.gsk.com/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg\",\"startDate\":\"2024-05-22\"},{\"@type\":\"Event\",\"name\":\"Berenberg European Conference\",\"description\":\"David Redfern, President, Corporate Development, attended the Berenberg European Conference in New York on Tuesday, 21 May 2024.\",\"image\":\"https://www.gsk.com/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg\",\"startDate\":\"2024-05-21\"},{\"@type\":\"Event\",\"name\":\"Barclays European Select Conference\",\"description\":\"David Redfern, President, Corporate Development, attended the Barclays European Select Conference in New York on Monday, 20 May 2024.\",\"image\":\"https://www.gsk.com/media/voshwb4z/gskh_04_2022_port_david_02_hess_thumb.jpg\",\"startDate\":\"2024-05-20\"},{\"@type\":\"Event\",\"name\":\"BNP Paribas Exane Healthcare Conference, Virtual\",\"description\":\"Julie Brown, Chief Financial Officer, participated in a fireside chat at the BNP Paribas Exane Healthcare Conference which took place on Tuesday, 26 March 2024.\",\"image\":\"https://www.gsk.com/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg\",\"startDate\":\"2024-03-26\"},{\"@type\":\"Event\",\"name\":\"ESG Investor Education Event (ESG Performance Report)\",\"description\":\"GSK\\u2019s VP of Reputation and Responsible Business, Clare Griffin, and VP of Sustainability, Claire Lund, presented a 45 minute virtual event focused on the newest set of ESG data for the company \\u2013 the 2023 ESG Performance Report.\",\"image\":\"https://www.gsk.com/media/30qjl55f/esg-report-2023-conference.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the webcast\",\"url\":\"https://youtu.be/em0EF-xaHOI\"},\"startDate\":\"2024-03-19\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Presentation\",\"contentUrl\":\"https://www.gsk.com/media/fjbgkye0/esg-investor-education-event-esg-performance-report-presentation.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Transcript\",\"contentUrl\":\"https://www.gsk.com/media/hbif2nbf/esg-investor-education-event-esg-performance-report-transcript.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"Berenberg UK Corporate Conference, Watford\",\"description\":\"Julie Brown, Chief Financial Officer, attended the Berenberg UK Corporate Conference on Tuesday, 19 March 2024.\",\"image\":\"https://www.gsk.com/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg\",\"startDate\":\"2024-03-19\"},{\"@type\":\"Event\",\"name\":\"TD Cowen Healthcare Conference\",\"description\":\"Luke Miels, Chief Commercial Officer, participated in a fireside chat at TD Cowen\\u0027s Healthcare Conference taking place on Monday 4 March at 2:50pm ET / 7:50pm GMT.\",\"image\":\"https://www.gsk.com/media/s2bfepc3/luke-miels-389-edit.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Listen to the webcast\",\"url\":\"https://wsw.com/webcast/cowen154/gsk/1852462\"},\"startDate\":\"2024-03-04\"},{\"@type\":\"Event\",\"name\":\"UBS European Healthcare Conference, London\",\"description\":\"Julie Brown, Chief Financial Officer, attended the London UBS European Healthcare Conference on Tuesday, 28 February 2024.\",\"image\":\"https://www.gsk.com/media/r54fnjsl/ocjh1081_gsk-cfoportrait-0101-003.jpg\",\"startDate\":\"2024-02-28\"},{\"@type\":\"Event\",\"name\":\"42nd annual JP Morgan Healthcare Conference\",\"description\":\"Emma Walmsley, Chief Executive Officer, participated in the 42nd annual JP Morgan Healthcare Conference on Tuesday 9 January at 07:30-08:10am PST / 15:30-16:10 GMT. The 40 minute session included a presentation and a moderated Q\\u0026amp;A discussion.\",\"image\":\"https://www.gsk.com/media/octpfn4c/gskh_05_2022_port_emma_03_hess_thumb.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Listen to the webcast\",\"url\":\"https://jpmorgan.metameetings.net/events/healthcare24/sessions/49293-gsk/webcast?gpu_only=true\\u0026kiosk=true\"},\"startDate\":\"2024-01-09\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"JP Morgan Healthcare Conference presentation\",\"contentUrl\":\"https://www.gsk.com/media/rmllhk1d/2024-jp-morgan-healthcare-conference-presentation.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"JP Morgan Healthcare Conference transcript\",\"contentUrl\":\"https://www.gsk.com/media/tsvlrat3/jp-morgan-healthcare-conference-transcript.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"Getting ahead of Respiratory Diseases with GSK management\",\"description\":\"GSK management held a virtual event on 30 November at 8:00 AM EST / 1:00 PM GMT. The event featured a presentation and an interactive Q\\u0026amp;A session. A replay is available on demand.\",\"image\":\"https://www.gsk.com/media/a1papyuy/lungs-science-image.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the recording\",\"url\":\"https://youtu.be/DCFrv0h2yhc\"},\"startDate\":\"2023-11-30\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Getting ahead of respiratory diseases presentation\",\"contentUrl\":\"https://www.gsk.com/media/5aepp4r0/gsk_respi-mtm_getting-ahead-of-respiratory-diseases.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Getting ahead of respiratory diseases transcript\",\"contentUrl\":\"https://www.gsk.com/media/sbspp0i2/getting-ahead-of-respiratory-diseases-with-gsk-management-transcript.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"Evercore ISI HealthCONx Conference\",\"description\":\"Phil Dormitzer, SVP and Global Head Vaccines R\\u0026amp;D and Infectious Disease Research, discussed the progress being made in vaccine innovation during a fireside chat at the Evercore ISI HealthCONx Conference on Wednesday, 29 November 2023, 12:30pm UK / 7:30am ET.\",\"image\":\"https://www.gsk.com/media/bu0bd4we/phil-dormitzer.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Listen to the webcast\",\"url\":\"https://wsw.com/webcast/evercore39/gsk/2177059\"},\"startDate\":\"2023-11-29\"},{\"@type\":\"Event\",\"name\":\"Redburn Atlantic CEO Conference\",\"description\":\"Luke Miels, Chief Commercial Officer, discussed the progress being made at GSK during a fireside chat at the Redburn Atlantic CEO Conference on Wednesday, 29 November 2023 at 9:00am UK.\",\"image\":\"https://www.gsk.com/media/s2bfepc3/luke-miels-389-edit.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the webcast\",\"url\":\"https://wsw.com/webcast/redburn7/gsk/1989197\"},\"startDate\":\"2023-11-29\"},{\"@type\":\"Event\",\"name\":\"Jefferies London Healthcare Conference\",\"description\":\"Tony Wood, Chief Scientific Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Thursday, 16 November at 9:00am GMT.\",\"image\":\"https://www.gsk.com/media/45khexa4/tony-16x9.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the webcast\",\"url\":\"https://wsw.com/webcast/jeff287/gsk/1707404\"},\"startDate\":\"2023-11-16\"},{\"@type\":\"Event\",\"name\":\"Getting ahead of HIV with ViiV Healthcare management\",\"description\":\"ViiV Healthcare management held a virtual event on 28 September at 9:00 AM EDT / 2:00 PM BST. The event, \\u0022Getting ahead of HIV,\\u0022 featured a presentation and an interactive Q\\u0026amp;A. A recording of the session is available on YouTube.\",\"image\":\"https://www.gsk.com/media/hkuiwef2/hiv_octane_ry_6k_still_1280x720px.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the recording\",\"url\":\"https://www.youtube.com/watch?v=vyKGSHZ_xSs\"},\"startDate\":\"2023-09-28\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Getting ahead of HIV together presentation\",\"contentUrl\":\"https://www.gsk.com/media/bjxlq3hp/gsk_viiv-mtm_getting-ahead-of-hiv-together_20230928.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Getting ahead of HIV together transcript\",\"contentUrl\":\"https://www.gsk.com/media/0qrlbtd4/getting-ahead-of-hiv-together-transcript.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"BofA 2023 Global Healthcare Conference\",\"description\":\"Emma Walmsley, Chief Executive Officer, participated in a fireside chat at the BofA Global Healthcare Conference on Thursday 14 September at 09:05 BST.\",\"image\":\"https://www.gsk.com/media/octpfn4c/gskh_05_2022_port_emma_03_hess_thumb.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Listen to the webcast\",\"url\":\"https://bofa.veracast.com/webcasts/bofa/globalhealthcareuk2023/id59v9PR.cfm\"},\"startDate\":\"2023-09-14\"},{\"@type\":\"Event\",\"name\":\"Citi\\u2019s 18th Annual BioPharma Conference\",\"description\":\"Phil Dormitzer, SVP, Head of Vaccines R\\u0026amp;D joined Andrew Baum in a fireside chat at Citi\\u2019s 18th Annual BioPharma Conference which took place Thursday, September 7th at 8:50am ET/1:50pm UK.\",\"image\":\"https://www.gsk.com/media/bu0bd4we/phil-dormitzer.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Listen to the webcast\",\"url\":\"https://kvgo.com/citi/gsk-plc-sept-2023\"},\"startDate\":\"2023-09-07\"},{\"@type\":\"Event\",\"name\":\"Getting ahead of Infectious Disease with GSK management\",\"description\":\"The virtual event featured a presentation, four breakout sessions and an interactive Q\\u0026amp;A. Recordings of all sessions are available on YouTube.\",\"image\":\"https://www.gsk.com/media/wtdd31rm/gsk_shingles-002.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the recordings\",\"url\":\"https://www.youtube.com/playlist?list=PLvDyxtKlIcnjFWjCU3fYGhbzwz9w8WnCz\"},\"startDate\":\"2023-06-27\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Opening and plenary session\",\"contentUrl\":\"https://www.gsk.com/media/rsnkk2se/20230620-evnt-id23-bos0.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Breakout 1 - Seasonal respiratory viruses\",\"contentUrl\":\"https://www.gsk.com/media/vcabtcuh/20230620-evnt-id23-bos10-edited.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Breakout 2 - Bacterial and fungal infections\",\"contentUrl\":\"https://www.gsk.com/media/43zfbfyb/20230620-evnt-id23-bos2.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Breakout 3 - Chronic viral infections\",\"contentUrl\":\"https://www.gsk.com/media/52chunix/20230620-evnt-id23-bos3.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Breakout 4 - Delivering health impact at scale\",\"contentUrl\":\"https://www.gsk.com/media/f3an4jmq/20230620-evnt-id23-bos4.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"Goldman Sachs\\u2019 44th Annual Global Healthcare Conference\",\"description\":\"Tony Wood, Chief Scientific Officer, discussed progress made in R\\u0026amp;D during a fireside chat on Tuesday, 13 June at 9:20am PT/12:20pm ET/5:20pm UK during Goldman Sachs\\u2019 44th Annual Global Healthcare Conference, in Dana Point, California.\",\"image\":\"https://www.gsk.com/media/45khexa4/tony-16x9.jpg\",\"startDate\":\"2023-06-13\",\"workFeatured\":{\"@type\":\"DataDownload\",\"name\":\"Download audio\",\"contentUrl\":\"https://www.gsk.com/media/cm1ma4ex/gsk-goldman-sachs-global-healthcare-conference-audio.mp3\",\"encodingFormat\":\"audio/mpeg\"}},{\"@type\":\"Event\",\"name\":\"ESG Investor Education Event (Clinical Trial Diversity)\",\"description\":\"During the 45 minute session Alberto Fernandez, SVP of Global Clinical Operations at GSK and Dr. Kimberly Smith, SVP and Head of R\\u0026amp;D at ViiV Healthcare, provided insights on the importance of clinical trial diversity including support from a 17-year retrospective study. During the session, the leaders also provided an overview of GSK\\u2019s work to ensure clinical trials reflect the populations most impacted by a disease and explored a HIV case study that demonstrated the power of clinical trial diversity in action. The presentation was followed by an opportunity for audience Q\\u0026amp;A.\",\"image\":\"https://www.gsk.com/media/foonktgv/esg-investor-education-event-clinical-trial-diversity.jpg\",\"startDate\":\"2023-06-06\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Download audio\",\"contentUrl\":\"https://www.gsk.com/media/sh3pwtfi/399015083.mp3\",\"encodingFormat\":\"audio/mpeg\"},{\"@type\":\"DataDownload\",\"name\":\"Clinical Trial Diversity presentation\",\"contentUrl\":\"https://www.gsk.com/media/qvkhuc2o/clinical-trial-diversity-presentation.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"41st annual JP Morgan Healthcare Conference \",\"description\":\"Emma Walmsley, Chief Executive Officer, presented at the 41st annual JP Morgan Healthcare Conference on Tuesday 10 January at 07:30-08:10am PT / 15:30-16:10 GMT. The 40 minute session included a presentation and a moderated Q\\u0026amp;A discussion.\\u0026nbsp;\",\"image\":\"https://www.gsk.com/media/ixfplhy0/gskh_05_2022_port_emma_04_hess.jpg\",\"startDate\":\"2023-01-10\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Download audio\",\"contentUrl\":\"https://www.gsk.com/media/10snqu1g/gsk-jpm-presentation-10-jan-2023.mp3\",\"encodingFormat\":\"audio/mpeg\"},{\"@type\":\"DataDownload\",\"name\":\"JP Morgan Healthcare Conference Presentation\",\"contentUrl\":\"https://www.gsk.com/media/22dklggv/20230109-cnfr-jpmorgan-prsn-all-sent.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"JP Morgan Healthcare Conference Transcript\",\"contentUrl\":\"https://www.gsk.com/media/3qtakwu1/gsk-jpm-transcript-10-jan-2023.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"Evercore ISI HealthCONx Conference \",\"description\":\"Deborah Waterhouse, Chief Executive Officer of ViiV Healthcare, and Dr. Kimberly Smith, Head of R\\u0026amp;D at ViiV Healthcare, discussed the progress being made in HIV innovation during a fireside chat at the Evercore ISI HealthCONx Conference Wednesday, November 30th, 1pm UK / 8:00am ET.\",\"image\":\"https://www.gsk.com/media/sedfczop/deborah-and-kim.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Listen to the webcast\",\"url\":\"https://wsw.com/webcast/evercore29/register.aspx?conf=evercore29\\u0026page=gsk\\u0026url=https://wsw.com/webcast/evercore29/gsk/2175870\"},\"startDate\":\"2022-11-30\"},{\"@type\":\"Event\",\"name\":\"Jefferies London Healthcare Conference\",\"description\":\"David Redfern, Chief Strategy Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, 16 November 2022 at 09:45 GMT.\",\"image\":\"https://www.gsk.com/media/vk5kqg4c/gskh_04_2022_port_david_02_hess.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Listen to the webcast\",\"url\":\"https://wsw.com/webcast/jeff255/register.aspx?conf=jeff255\\u0026page=gsk\\u0026url=https://wsw.com/webcast/jeff255/gsk/1701459\"},\"startDate\":\"2022-11-16\"},{\"@type\":\"Event\",\"name\":\"Response to Investor Forum Letter\",\"description\":\"GSK\\u2019s response to an Investor Forum letter, regarding GSK\\u2019s redefined operating model post-Demerger.\",\"image\":\"https://www.gsk.com/media/klagpt2g/sir-jonathan-symonds-2.jpeg\",\"startDate\":\"2022-10-28\",\"workFeatured\":{\"@type\":\"DataDownload\",\"name\":\"GSK\\u2019s response to an Investor Forum letter\",\"contentUrl\":\"https://www.gsk.com/media/mssgzi3n/gsk-response-to-mr-andy-griffiths-the-investor-forum-letter.pdf\",\"encodingFormat\":\"application/pdf\"}},{\"@type\":\"Event\",\"name\":\"Investor science event: Getting ahead of respiratory syncytial virus in older adults\",\"description\":\"After presenting the positive AReSVi-006 pivotal phase III results for our RSV (respiratory syncytial virus) older adults vaccine candidate at IDWeek 2022, GSK management hosted an investor science event on 21 October 2022.\",\"image\":\"https://www.gsk.com/media/x3zob3rp/gsk_rsv_updated_close_still_6k_cmyk.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Listen to the webcast\",\"url\":\"https://www.investis-live.com/gsk/6346d81f3bb8290c00a4e48c/qergq\"},\"startDate\":\"2022-10-21\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"GSK RSV Investor Science Event ID Week 2022\",\"contentUrl\":\"https://www.gsk.com/media/rsrmvfku/gsk-rsv-investor-science-event-id-week-2022.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"GSK RSV Older Adults Investor Briefing Document\",\"contentUrl\":\"https://www.gsk.com/media/hiffccnt/gsk-rsv-older-adults-investor-briefing-document-oct-2022.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"BofA 2022 Global Healthcare Conference\",\"description\":\"Emma Walmsley, CEO, participated in a fireside chat at the BofA Global Healthcare Conference on Friday 16 September at 0815 BST.\",\"image\":\"https://www.gsk.com/media/ixfplhy0/gskh_05_2022_port_emma_04_hess.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the webcast\",\"url\":\"https://bofa.veracast.com/webcasts/bofa/globalhealthcareuk2022/idxD2o25.cfm\"},\"startDate\":\"2022-09-16\"},{\"@type\":\"Event\",\"name\":\"Citi 17th Annual BioPharma Conference\",\"description\":\"Roger Connor, President Global Vaccines \\u0026amp; Global Health and Phil Dormitzer, SVP, Head of Vaccines R\\u0026amp;D joined Andrew Baum in a fireside chat at Citi\\u2019s 17th Annual BioPharma Conference which took place Wednesday, September 7 at 1:50pm ET/6:50pm UK.\\u0026nbsp;\",\"image\":\"https://www.gsk.com/media/xyhdptld/roger-and-phil.png\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the webcast\",\"url\":\"https://www.veracast.com/webcasts/citigroup/biopharma2022/7lva92.cfm\"},\"startDate\":\"2022-09-07\"},{\"@type\":\"Event\",\"name\":\"dbAccess Global Consumer Conference 2022\",\"description\":\"Tobias Hestler, CFO GSK Consumer Healthcare participated in a fireside chat at the dB Access Global Consumer Conference on 14th June 2022 at 14:45pm BST (15:45pm CEST, 9:45am EDT).\\r\\n\\u00A0\",\"image\":\"https://www.gsk.com/media/5nxjmx5y/662718_gsk_tobias_hestler_01_head_500px-ubs-global-consumer-and-retail-conference-2022.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the webcast\",\"url\":\"https://kvgo.com/deutsche-bank/glaxo-smith-kline-plc-june-2022\"},\"startDate\":\"2022-06-14\"},{\"@type\":\"Event\",\"name\":\"Goldman Sachs 43rd Annual Global Healthcare Conference\",\"description\":\"Deborah Waterhouse, CEO, ViiV Healthcare, and Dr. Kimberly Smith, Head of R\\u0026amp;D, ViiV Healthcare, discussed progress being made in the HIV space during a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference, Monday, June 13th\\u0026nbsp;at 10:00pm UK / 5:00pm ET\",\"image\":\"https://www.gsk.com/media/uqhc0knu/deborah-kim-viiv-306x172.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the webcast\",\"url\":\"https://kvgo.com/gs/glaxo-smith-kline-june-2022\"},\"startDate\":\"2022-06-13\"},{\"@type\":\"Event\",\"name\":\"UBS Global Healthcare Conference 2022\",\"description\":\"Dr. Kimberly Smith, Head of R\\u0026amp;D, ViiV Healthcare, discussed progress being made in HIV innovation during a fireside chat at the UBS Global Healthcare Conference on Tuesday, May 24th\\u0026nbsp;at 2:15pm UK / 9:15am ET.\\u200B\",\"image\":\"https://www.gsk.com/media/wmohq2hq/gsk_k_smith_0298-1.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the webcast\",\"url\":\"https://kvgo.com/ubs-global-healthcare-2022/glaxosmithkline-plc-may\"},\"startDate\":\"2022-05-24\"},{\"@type\":\"Event\",\"name\":\"JPMorgan CEO Consumer Staples fireside chat series\",\"description\":\"Brian McNamara, CEO Designate of Consumer Healthcare, participated in a fireside chat with JPMorgan analyst Celine Pannuti as part of her series of discussions with consumer staples CEOs. In the conversation Brian discussed the growth outlook across various consumer health categories, recent innovation trends and progress towards becoming a standalone company.\\u0026nbsp;\",\"image\":\"https://www.gsk.com/media/bdokxuoe/662718_gsk_brian_mcnamara_02_head_500px-jpmorgan-ceo-consumer-staples-fireside-chat-series.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the webcast. Access code: 368408\",\"url\":\"https://ige.netroadshow.com/replay/7653/european-consumer-ceo-fireside-chat--haleon--brian-mcnamara/\"},\"startDate\":\"2022-05-20\"},{\"@type\":\"Event\",\"name\":\"ESG Investor Education Event (Environment)\",\"description\":\"Claire Lund, Vice President Environmental Sustainability, hosted our first ESG Investor Education Event\\u0026nbsp;focusing on our environment strategy, 5 April 2022 at 15:00 BST / 10:00 EDT.\",\"image\":\"https://www.gsk.com/media/zpqf1cre/claire-lund-photo-esg-investor-education-event-environment.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the replay\",\"url\":\"https://www.youtube.com/watch?v=iB7SzptcvS8\\u0026feature=youtu.be\"},\"startDate\":\"2022-04-05\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Presentation\",\"contentUrl\":\"https://www.gsk.com/media/inmnodqs/gsk_investoreducationevent_20220405-1.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Transcript\",\"contentUrl\":\"https://www.gsk.com/media/roxgr4h5/gsk-investoreducation-5apr22_transcript.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"UBS Global Consumer and Retail Conference 2022\",\"description\":\"Tobias Hestler, CFO Designate of Consumer Healthcare, participated in a fireside chat at the UBS Global Consumer and Retail Conference hosted by UBS analyst Guillaume Delmas.\",\"image\":\"https://www.gsk.com/media/5nxjmx5y/662718_gsk_tobias_hestler_01_head_500px-ubs-global-consumer-and-retail-conference-2022.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the webcast\",\"url\":\"https://kvgo.com/ubs/glaxo-smith-kline-plc-march-2022\"},\"startDate\":\"2022-03-09\"},{\"@type\":\"Event\",\"name\":\"Cowen 42nd Annual Health Care Conference\",\"description\":\"Hal Barron, Chief Scientific Officer and President R\\u0026amp;D, discussed the progress GSK is making in R\\u0026amp;D during a fireside chat at the Cowen 42nd Annual Health Care Conference taking place virtually on Monday, 7 March 2022 at 4:10pm UK/11:10pm ET.\",\"image\":\"https://www.gsk.com/media/axcjh0m1/halbarron-cowen-42nd-annual-health-care-conference.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the webcast\",\"url\":\"https://wsw.com/webcast/cowen108/register.aspx?conf=cowen108\\u0026page=gsk\\u0026url=https://wsw.com/webcast/cowen108/gsk/1851273\"},\"startDate\":\"2022-03-07\"},{\"@type\":\"Event\",\"name\":\"GSK Consumer Healthcare Capital Markets Day\",\"description\":\"GSK\\u0027s Consumer Healthcare Capital Markets Day took place on Monday 28 February 2022. This event provided details on our strategy, brands, capabilities and operations, as well as detailed financial information and future growth ambitions ahead of the proposed listing on the London Stock Exchange following the anticipated demerger from GSK mid-2022.\",\"image\":\"https://www.gsk.com/media/ss4jxmo4/power-brands-with-logo-gsk-consumer-healthcare-capital-markets-day.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Capital Markets Day Webcast platform\",\"url\":\"https://gskch.connectid.cloud/\"},\"startDate\":\"2022-02-28\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Haleon Capital Markets Day All Presentation Slides\",\"contentUrl\":\"https://www.gsk.com/media/t30f0rmg/haleon-capital-markets-day-all-presentation-slides.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Haleon Capital Markets Day Full Presentation Transcript\",\"contentUrl\":\"https://www.gsk.com/media/zy3d3sj3/haleon-capital-markets-day-full-presentation-transcript.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Haleon Factsheet\",\"contentUrl\":\"https://www.gsk.com/media/uk4janzp/haleon-factsheet.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"FCLT Global presents \\u201CInvesting in Healthcare Innovations: A Case Study of Multi-stakeholder Capitalism in Practice\\u0022\",\"description\":\"Roger Connor, President Global Vaccines \\u0026amp; Global Health, particpated in a panel hosted by FCLT Global on Thursday, February 10th\\u0026nbsp;at 8:00am ET/1:00pm GMT.\\u0026nbsp; The panel focused on navigating the complexity of long-term strategies and investment since financing healthcare advancements, and particularly vaccine development, became central priority with the onset of COVID19.\",\"image\":\"https://www.gsk.com/media/lnhhxmtv/roger-1118x630-fclt-global-presents-investing-in-healthcare-innovations-a-case-study-of-multi-stakeholder-capitalism-in-practice.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Watch the Webinar\",\"url\":\"https://www.fcltglobal.org/resource/healthcare-innovations-webinar/\"},\"startDate\":\"2022-02-10\"},{\"@type\":\"Event\",\"name\":\"JP Morgan Healthcare Conference 2022\",\"description\":\"Emma Walmsley, Chief Executive Officer, presented at the 40th annual JP Morgan Healthcare Conference on Tuesday 11 January at 07:30-08:10am ET / 12:30-13:10 GMT. The 40 minute session included a presentation and a moderated Q\\u0026amp;A discussion.\\u0026nbsp;\",\"image\":\"https://www.gsk.com/media/lrpixwp5/emma-walmsley-gold-jp-morgan-healthcare-conference-2022.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Listen to the audio\",\"url\":\"https://jpmorgan.metameetings.net/events/healthcare22/sessions/39843-glaxosmithkline/webcast\"},\"startDate\":\"2022-01-11\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"JP Morgan Healthcare Conference Presentation\",\"contentUrl\":\"https://www.gsk.com/media/b04ksiwl/jp-morgan-healthcare-conference-presentation.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"JP Morgan Healthcare conference transcript\",\"contentUrl\":\"https://www.gsk.com/media/4qbnxirl/jpm-gsk-transcript-11-jan-2022.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference\",\"description\":\"Emma Walmsley, Chief Executive Officer, participated in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference: A View from the Top, on Thursday, 6 January 2022 at 8:00am ET.\",\"image\":\"https://www.gsk.com/media/xbmbl25r/ascr1509_cc_resized-bofa-2021-global-healthcare-conference.jpeg\",\"startDate\":\"2022-01-06\"},{\"@type\":\"Event\",\"name\":\"Morgan Stanley ESG Insights Conference 2021\",\"description\":\"Harmony Garges, SVP and Chief Medical Officer ViiV Healthcare, presented at the virtual Morgan Stanley ESG Insights Conference and provided an overview of ViiV\\u2019s mission to leave no person living with HIV behind and how it aligns with ViiV\\u2019s ESG efforts.\",\"image\":\"https://www.gsk.com/media/hfud1vky/harmony-garges-morgan-stanley-esg-insights-conference-2021.jpeg\",\"startDate\":\"2021-12-02\",\"workFeatured\":{\"@type\":\"DataDownload\",\"name\":\"Morgan Stanley ESG Insights Conference presentation\",\"contentUrl\":\"https://www.gsk.com/media/lhrh2viz/ms-esg-garges_draft_1dec21_final.pdf\",\"encodingFormat\":\"application/pdf\"}},{\"@type\":\"Event\",\"name\":\"Redburn CEO conference 2021\",\"description\":\"Brian McNamara, CEO of GSK Consumer Healthcare, participated in a virtual fireside chat at the 2021 Redburn CEO Conference. He provided an overview of our business and broader industry.\",\"image\":\"https://www.gsk.com/media/5nxc154b/brian-mcnamara-gsk-redburn-ceo-conference-2021.jpeg\",\"startDate\":\"2021-12-01\"},{\"@type\":\"Event\",\"name\":\"Meet GSK management: getting ahead of HIV\",\"description\":\"GSK hosted a \\u2018Meet GSK management\\u2019 event on 29 November 2021 at 15:00 GMT / 10:00 EST.\",\"image\":\"https://www.gsk.com/media/r1hpl4oz/david-deborah-kim-meet-gsk-management-getting-ahead-of-hiv.jpg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Webcast registration\",\"url\":\"https://www.investis-live.com/gsk/618a4cac75c49013003814bb/bdft\"},\"startDate\":\"2021-11-29\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Getting ahead of HIV presentation\",\"contentUrl\":\"https://www.gsk.com/media/0z5pips4/gsk_getting_ahead_of_hiv-evnt-presentation-29-nov-21.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Getting ahead of HIV transcript\",\"contentUrl\":\"https://www.gsk.com/media/o2yhodzi/gsk-hiv-event-transcript-29nov21.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"UBS European Conference 2021\",\"description\":\"Tobias Hestler, CFO GSK Consumer Healthcare, participated in a virtual fireside chat at the UBS European Conference hosted by analyst Guillaume Delmas.\",\"image\":\"https://www.gsk.com/media/1jggtsjw/tobias-hestler-our-leaders-328x202-bernstein-annual-pan-european-strategic-decisions-conference.jpg\",\"startDate\":\"2021-11-09\"},{\"@type\":\"Event\",\"name\":\"Investor science event: ASN Kidney Week 2021\",\"description\":\"GSK held an investor science event for daprodustat\\u2019s ASCEND Phase III programme at 12 noon EST/ 5pm GMT on 7 November 2021.\",\"image\":\"https://www.gsk.com/media/ppidcvl4/hal-barron-luke-miels-306-x-172.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Register to the webcast\",\"url\":\"https://www.investis-live.com/gsk/616d98332a563a1200a6af57/etad\"},\"startDate\":\"2021-11-07\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"ASN 2021 presentation\",\"contentUrl\":\"https://www.gsk.com/media/ttnngwup/20211105-prsn-asn-2021-website-slides-only.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"ASN 2021 transcript\",\"contentUrl\":\"https://www.gsk.com/media/me2nlqzq/gsk-investorevent-transcript-7nov21.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"The Investor Forum\",\"description\":\"Sir Jonathan Symonds, Chairman, and Manvinder Singh Banga, Senior Independent Non-Executive Director, participated in an Investor Forum meeting on Thursday 7 October 2021.\",\"image\":\"https://www.gsk.com/media/exllbj5f/jon_vindi-the-investor-forum.jpeg\",\"startDate\":\"2021-10-07\",\"workFeatured\":{\"@type\":\"DataDownload\",\"name\":\"Presentation slides\",\"contentUrl\":\"https://www.gsk.com/media/mdecqxcu/investor-forum-slides.pdf\",\"encodingFormat\":\"application/pdf\"}},{\"@type\":\"Event\",\"name\":\"Guggenheim 2nd Annual Vaccine and Infectious Disease Day\",\"description\":\"Rino Rappuoli, Senior Vice President Global Head of Vaccines R\\u0026amp;D, participated in a fireside chat at Guggenheim\\u2019s 2nd Annual Vaccine and Infectious Disease Day which took place on Wednesday 6 October 2021 at 1:00pm ET.\\u0026nbsp;\",\"image\":\"https://www.gsk.com/media/0ojfre14/rino-rappuoli-guggenheim-2nd-annual-vaccine-and-infectious-disease-day.jpeg\",\"startDate\":\"2021-10-06\"},{\"@type\":\"Event\",\"name\":\"Bernstein Annual Pan European Strategic Decisions Conference\",\"description\":\"Tobias Hestler, CFO for GSK Consumer Healthcare participated in a virtual fireside chat at the Bernstein Annual Pan European Strategic Decisions Conference.\",\"image\":\"https://www.gsk.com/media/0kshuold/tobias-hestler-our-leaders-328x202-bernstein-annual-pan-european-strategic-decisions-conference.jpg\",\"startDate\":\"2021-09-22\"},{\"@type\":\"Event\",\"name\":\"BofA 2021 Global Healthcare Conference\",\"description\":\"Emma Walmsley, CEO, participated in a fireside chat at the BofA Global Healthcare Conference on Friday 17 September at 0815 BST.\",\"image\":\"https://www.gsk.com/media/xbmbl25r/ascr1509_cc_resized-bofa-2021-global-healthcare-conference.jpeg\",\"startDate\":\"2021-09-17\"},{\"@type\":\"Event\",\"name\":\"Barclay\\u2019s Global Consumer Staples conference\",\"description\":\"Brian McNamara, CEO GSK Consumer Healthcare, joined a virtual fireside chat hosted by Barclay\\u2019s analyst, Iain Simpson.\\u0026nbsp; He provided an overview of the Consumer Healthcare business and our category leading brands.\\u0026nbsp;\",\"image\":\"https://www.gsk.com/media/h3mcevqj/brian-mcnamara-barclay-s-global-consumer-staples-conference.jpeg\",\"startDate\":\"2021-09-10\"},{\"@type\":\"Event\",\"name\":\"Citi 16th Annual Biopharma Conference\",\"description\":\"Dr. Kimberly Smith, Head of R\\u0026amp;D, ViiV Healthcare participated in a fireside chat at Citi\\u2019s 16th Annual Biopharma Conference taking place on Thursday 9 September 2021 at 18:25 UK / 1:25pm EDT. Dr. Smith provided an update on ViiV Healthcare\\u2019s progress in advancing HIV science and R\\u0026amp;D.\",\"image\":\"https://www.gsk.com/media/wmohq2hq/gsk_k_smith_0298-1.jpeg\",\"startDate\":\"2021-09-09\"},{\"@type\":\"Event\",\"name\":\"Guggenheim\\u2019s Biopharma Strategy Series\",\"description\":\"Hal Barron, Chief Scientific Officer and President R\\u0026amp;D, joined a virtual fireside chat hosted by Guggenheim analyst Seamus Fernandez at Guggenheim\\u2019s Biopharma Strategy Series.\\nThe event, \\u0027Biopharma\\u0027s Next Decade: Views from the Top on Global Strategy and Innovation\\u0027 took place Tuesday, 29 June 2021 at 19:00 BST / 14:00 EDT, during which he provided an update on the progress GSK is making in R\\u0026amp;D.\",\"image\":\"https://www.gsk.com/media/axcjh0m1/halbarron-cowen-42nd-annual-health-care-conference.jpeg\",\"startDate\":\"2021-06-29\"},{\"@type\":\"Event\",\"name\":\"New GSK Investor update\",\"description\":\"Emma Walmsley, CEO, and other members of CET hosted a virtual investor update at 14:00-17:30 BST on Wednesday 23 June. The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.\",\"image\":\"https://www.gsk.com/media/xbmbl25r/ascr1509_cc_resized-bofa-2021-global-healthcare-conference.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Link to the event webcast\",\"url\":\"https://gsk.connectid.cloud/\"},\"startDate\":\"2021-06-23\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Presentation slides\",\"contentUrl\":\"https://www.gsk.com/media/yd1f1rpu/gsk-investor-update_23-06-21.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Presentation transcript\",\"contentUrl\":\"https://www.gsk.com/media/wksd3smy/presentation-transcript.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Q\\u0026A transcript\",\"contentUrl\":\"https://www.gsk.com/media/ca1jupwo/qa-transcript.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Epidemiology data\",\"contentUrl\":\"https://www.gsk.com/media/rjtd4l3v/epidemiology-data.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"Clinical trials summary\",\"contentUrl\":\"https://www.gsk.com/media/xwqdtooo/clinical-trials-summary.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"Exane BNP Paribas 23rd European CEO Conference\",\"description\":\"Brian McNamara, CEO, GSK Consumer Healthcare, presented at the conference and provided an introduction to GSK Consumer Healthcare and outlined our purpose, strategy, category-leading brands and capabilities, as well as an overview of the consumer healthcare sector.\",\"image\":\"https://www.gsk.com/media/5nxc154b/brian-mcnamara-gsk-redburn-ceo-conference-2021.jpeg\",\"startDate\":\"2021-06-10\",\"workFeatured\":{\"@type\":\"DataDownload\",\"name\":\"Exane June 21 Show File Vf\",\"contentUrl\":\"https://www.gsk.com/media/0wyaagyf/exane-june-21-show-file-vf.pdf\",\"encodingFormat\":\"application/pdf\"}},{\"@type\":\"Event\",\"name\":\"CECP Biopharma Investor Forum\",\"description\":\"Emma Walmsley, CEO, presented at CECP\\u2019s Biopharma Investor Forum on Tuesday 8 June at 8:40 EST/13:40 BST, during which she provided an overview on our approach to ESG. The presentation was followed by a moderated Q\\u0026amp;A session.\",\"image\":\"https://www.gsk.com/media/rwtblo2t/emma-walmsley-1.jpeg\",\"startDate\":\"2021-06-08\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"CECP presentation slides\",\"contentUrl\":\"https://www.gsk.com/media/lkjlhdh5/cecp-presentation-070621-pdf-version-of-slides.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"CECP presentation script\",\"contentUrl\":\"https://www.gsk.com/media/msgpdekp/script-word-version-070621-pdf.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"Barclays Global Healthcare Conference 2021\",\"description\":\"Deborah Waterhouse, CEO of ViiV Healthcare, participated in a fireside chat at the Barclays Global Healthcare Conference on Wednesday, March 10 at 8:35am ET/1:35pm GMT, during which she provided an update on the progress GSK is making in the HIV space.\",\"image\":\"https://www.gsk.com/media/mqojwrtq/dw_gskcom_biog_page_1118x630.jpeg\",\"startDate\":\"2021-03-10\"},{\"@type\":\"Event\",\"name\":\"Cowen 41st Annual Health Care Conference\",\"description\":\"Hal Barron, Chief Scientific Officer and President R\\u0026amp;D, participated in a fireside chat at the Cowen 41st Annual Health Care Conference on Monday, March 1 2021 at 5:20pm GMT /12:20pm ET, during which he discussed updates on the progress GSK is making in R\\u0026amp;D.\",\"image\":\"https://www.gsk.com/media/axcjh0m1/halbarron-cowen-42nd-annual-health-care-conference.jpeg\",\"startDate\":\"2021-03-01\"},{\"@type\":\"Event\",\"name\":\"Guggenheim Healthcare Talks 2021\",\"description\":\"Axel Hoos, GSK Senior Vice-President Oncology R\\u0026amp;D, joined a Fireside Chat with Seamus Fernandez at the Guggenheim Healthcare Talks 2021 Oncology Days, Thursday, February 11, at 10AM ET, where the duo discussed GSK Oncology R\\u0026amp;D progress.\",\"image\":\"https://www.gsk.com/media/xc3du2eu/axel-hoos.jpeg\",\"startDate\":\"2021-02-11\"},{\"@type\":\"Event\",\"name\":\"39th annual JP Morgan Virtual Healthcare Conference\",\"description\":\"Hal Barron, Chief Scientific Officer and President R\\u0026amp;D, presented at the 39th annual JP Morgan Virtual Healthcare Conference on Tuesday 12 January at 10:50-11:30am ET / 15:50-16:30 GMT.\\u0026nbsp; The presentation was followed by a Q\\u0026amp;A session.\\u0026nbsp;\",\"image\":\"https://www.gsk.com/media/axcjh0m1/halbarron-cowen-42nd-annual-health-care-conference.jpeg\",\"startDate\":\"2021-01-11\",\"workFeatured\":[{\"@type\":\"DataDownload\",\"name\":\"Gsk Jpm 2021 Final 12012021\",\"contentUrl\":\"https://www.gsk.com/media/l1anvqyf/gsk_jpm_2021_final_12012021.pdf\",\"encodingFormat\":\"application/pdf\"},{\"@type\":\"DataDownload\",\"name\":\"39Th Annual Jp Morgan Virtual Healthcare Conference Transcript\",\"contentUrl\":\"https://www.gsk.com/media/pdkkzosz/39th-annual-jp-morgan-virtual-healthcare-conference_transcript.pdf\",\"encodingFormat\":\"application/pdf\"}]},{\"@type\":\"Event\",\"name\":\"Goldman Sachs 13th Annual Healthcare Unscripted CEOs Conference\",\"description\":\"Emma Walmsley, CEO, hosted a fireside chat at the Goldman Sachs 13th annual healthcare unscripted CEOs conference on Tuesday 5 January at 12:00 GMT\",\"image\":\"https://www.gsk.com/media/rwtblo2t/emma-walmsley-1.jpeg\",\"startDate\":\"2021-01-05\"},{\"@type\":\"Event\",\"name\":\"Morgan Stanley ESG Insights Conference\",\"description\":\"Phil Thomson, President Global Affairs, hosted a fireside chat at the Morgan Stanley ESG Insights Conference on Wednesday, 9 December 2020 at 15:25 GMT / 10:25am EST.\",\"image\":\"https://www.gsk.com/media/k5ojxe0p/phil-thomson-gsk.jpeg\",\"subjectOf\":{\"@type\":\"WebPage\",\"name\":\"Morgan Stanley ESG Insights Conference webcast\",\"url\":\"https://morganstanley.webcasts.com/starthere.jsp?ei=1409569\\u0026tp_key=db07460803\"},\"startDate\":\"2020-12-09\",\"workFeatured\":{\"@type\":\"DataDownload\",\"name\":\"Morgan Stanley ESG Conference presentation\",\"contentUrl\":\"https://www.gsk.com/media/4dmnau1h/gsk-ms-esg-conf-2020-12-09.pdf\",\"encodingFormat\":\"application/pdf\"}}],\"numberOfItems\":100}}"]},"modules":[]}